1
|
Asumda FZ, Campbell NA, Hassan MA, Fathi R, Vasquez Rico DF, Kiem M, Vang EV, Kim YH, Luo X, O’Brien DR, Buhrow SA, Reid JM, Moore MJ, Ben-Yair VK, Levitt ML, Leiting JL, Abdelrahman AM, Zhu X, Lucien F, Truty MJ, Roberts LR. Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts. Cancers (Basel) 2024; 16:1050. [PMID: 38473407 PMCID: PMC10930726 DOI: 10.3390/cancers16051050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2024] [Revised: 02/16/2024] [Accepted: 02/18/2024] [Indexed: 03/14/2024] Open
Abstract
Upamostat is an orally available small-molecule serine protease inhibitor that is a highly potent inhibitor of trypsin 1, trypsin 2, trypsin 3 (PRSS1/2/3), and the urokinase-type plasminogen activator (uPA). These enzymes are expressed in many cancers, especially during tissue remodeling and subsequent tumor cell invasion. Opaganib (ABC294640), a novel, orally available small molecule is a selective inhibitor of the phosphorylation of sphingosine to sphingosine-1-phosphate (S-1-P) by sphingosine kinase 2 (SPHK2). Both sphingosine kinase 1 (SPHK1) and SPHK2 are known to regulate the proliferation-inducing compound S-1-P. However, SPHK2 is more critical in cancer pathogenesis. The goal of this project was to investigate the potential antitumor effects of upamostat and opaganib, individually and in combination, on cholangiocarcinoma (CCA) xenografts in nude mice. PAX165, a patient-derived xenograft (PDX) from a surgically resected CCA, expresses substantial levels of SPHK2, PRSS1, PRSS2, and PRSS3. Four groups of 18 mice each were treated with upamostat, opaganib, both, or vehicle. Mouse weights and PAX165 tumor volumes were measured. Tumor volumes in the upamostat, opaganib, and upamostat plus opaganib groups were significantly decreased compared to the control group.
Collapse
Affiliation(s)
- Faizal Z. Asumda
- Departments of Pediatrics and Pathology, Medical College of Georgia-Augusta University Medical Center, Augusta, GA 30912, USA;
| | - Nellie A. Campbell
- Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Mayo Clinic Cancer Center, Rochester, MN 55905, USA; (N.A.C.); (M.J.M.); (X.Z.)
| | | | - Reza Fathi
- RedHill Biopharma, Ltd., 21 Ha’arba’a St., Tel Aviv 6473921, Israel; (R.F.); (M.L.L.)
| | | | - Melanie Kiem
- Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Mayo Clinic Cancer Center, Rochester, MN 55905, USA; (N.A.C.); (M.J.M.); (X.Z.)
- Study of Human Medicine, Paracelsus Medical University, Strubergasse 21, 5020 Salzburg, Austria
| | - Ethan V. Vang
- Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Mayo Clinic Cancer Center, Rochester, MN 55905, USA; (N.A.C.); (M.J.M.); (X.Z.)
| | - Yo Han Kim
- Department of Urology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA; (Y.H.K.); (F.L.)
| | - Xin Luo
- Hepatic Surgery Center and Hubei Key Laboratory of Hepato-Pancreatic-Biliary Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China
| | - Daniel R. O’Brien
- Department of Quantitative Health Sciences, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA;
| | - Sarah A. Buhrow
- Department of Oncology and Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA; (S.A.B.); (J.M.R.)
| | - Joel M. Reid
- Department of Oncology and Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA; (S.A.B.); (J.M.R.)
| | - Michael J. Moore
- Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Mayo Clinic Cancer Center, Rochester, MN 55905, USA; (N.A.C.); (M.J.M.); (X.Z.)
| | - Vered Katz Ben-Yair
- RedHill Biopharma, Ltd., 21 Ha’arba’a St., Tel Aviv 6473921, Israel; (R.F.); (M.L.L.)
| | - Mark L. Levitt
- RedHill Biopharma, Ltd., 21 Ha’arba’a St., Tel Aviv 6473921, Israel; (R.F.); (M.L.L.)
| | - Jennifer L. Leiting
- Division of Subspecialty General Surgery, Department of Surgery, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA;
| | - Amro M. Abdelrahman
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA; (A.M.A.); (M.J.T.)
| | - Xinli Zhu
- Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Mayo Clinic Cancer Center, Rochester, MN 55905, USA; (N.A.C.); (M.J.M.); (X.Z.)
- Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310030, China
| | - Fabrice Lucien
- Department of Urology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA; (Y.H.K.); (F.L.)
| | - Mark J. Truty
- Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA; (A.M.A.); (M.J.T.)
| | - Lewis R. Roberts
- Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Mayo Clinic Cancer Center, Rochester, MN 55905, USA; (N.A.C.); (M.J.M.); (X.Z.)
| |
Collapse
|
2
|
Park SS, Kang H, Kim YH, Kim JH. Different tumor growth pattern of clinically nonfunctioning pituitary neuroendocrine tumor according to sex and age: a longitudinal study. J Endocrinol Invest 2024:10.1007/s40618-024-02303-8. [PMID: 38310625 DOI: 10.1007/s40618-024-02303-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Accepted: 01/02/2024] [Indexed: 02/06/2024]
Abstract
PURPOSE Asymptomatic patients with clinically non-functional pituitary neuroendocrine tumors (CNF-PitNETs) are usually followed up. However, the natural course of CNF-PitNETs according to sex and age remains unclear. Therefore, this study assessed growth patterns of CNF-PitNETs according to sex and age. METHODS In this longitudinal study, we enrolled 431 consecutive patients with CNF-PitNETs who were treated at Seoul National University Hospital from 1997 to 2021. The patients underwent hormone function testing and visual field testing, and were subsequently followed up with imaging over a median duration of 66 months. RESULTS The median age of the patients was 53.0 years, and 37.1% (n = 160) were men. Men were older and harbored more macroadenomas than women. The annual tumor volume change was higher in men than in women (0.21 vs. 0.04 cm3/year, P < 0.001). The estimated cutoff value of age for significant tumor growth was 51 years. In men, the annual tumor volume change was similar across all age groups. In women, those aged ≤ 50 years showed significantly lower annual tumor volume change than those aged > 50 years (0.01, 0.11, and 0.17 cm3/year, P = 0.001). When comparing sexes within the same age group, the annual tumor volume changes was significantly lower for women than for men, only in patients aged ≤ 50 years (0.01 vs. 0.15 cm3/year, P < 0.001). CONCLUSIONS Among patients with CNF-PitNET, tumor growth was slower in women aged ≤ 50 years than in men and women aged > 50. These findings may guide the customization of surveillance strategies for CNF-PitNETs according to sex and age.
Collapse
Affiliation(s)
- S S Park
- Department of Internal Medicine, Seoul National University College of Medicine, 101 Dae-hak ro, Seoul, 03080, Korea
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
- Pituitary Center, Seoul National University Hospital, Seoul, Korea
| | - H Kang
- Pituitary Center, Seoul National University Hospital, Seoul, Korea
- Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, 101 Dae-hak ro, Seoul, 03080, Korea
| | - Y H Kim
- Pituitary Center, Seoul National University Hospital, Seoul, Korea.
- Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, 101 Dae-hak ro, Seoul, 03080, Korea.
| | - J H Kim
- Department of Internal Medicine, Seoul National University College of Medicine, 101 Dae-hak ro, Seoul, 03080, Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- Pituitary Center, Seoul National University Hospital, Seoul, Korea.
| |
Collapse
|
3
|
Kim YH, Choi YR, Joo DJ, Baek WY, Suh YC, Oh WT, Cho JY, Lee SC, Kim SK, Ryu HJ, Jeon KO, Lee WJ, Hong JW. Reaching New Heights: A Comprehensive Study of Hand Transplantations in Korea after Institutionalization of Hand Transplantation Law. Yonsei Med J 2024; 65:108-119. [PMID: 38288651 PMCID: PMC10827641 DOI: 10.3349/ymj.2023.0365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/14/2023] [Revised: 10/26/2023] [Accepted: 11/02/2023] [Indexed: 02/01/2024] Open
Abstract
PURPOSE With the revision of the Organ and Transplantation Act in 2018, the hand has become legal as an area of transplantable organs in Korea. In January 2021, the first hand allotransplantation since legalization was successfully performed, and we have performed a total of three successful hand transplantation since then. By comparing and incorporating our experiences, this study aimed to provide a comprehensive reconstructive solution for hand amputation in Korea. MATERIALS AND METHODS Recipients were selected through a structured preoperative evaluation, and hand transplantations were performed at the distal forearm level. Postoperatively, patients were treated with three-drug immunosuppressive regimen, and functional outcomes were monitored. RESULTS The hand transplantations were performed without intraoperative complications. All patients had partial skin necrosis and underwent additional surgical procedures in 2 months after transplantation. After additional operations, no further severe complications were observed. Also, patients developed acute rejection within 3 months of surgery, but all resolved within 2 weeks after steroid pulse therapy. Motor and sensory function improved dramatically, and patients were very satisfied with the appearance and function of their transplanted hands. CONCLUSION Hand transplantation is a viable reconstructive option, and patients have shown positive functional and psychological outcomes. Although this study has limitations, such as the small number of patients and short follow-up period, we should focus on continued recovery of hand function, and be careful not to develop side effects from immunosuppressive drugs. Through the present study, we will continue to strive for a bright future regarding hand transplantation in Korea.
Collapse
Affiliation(s)
- Yo Han Kim
- Department of Plastic & Reconstructive Surgery, Yonsei University College of Medicine, Seoul, Korea
- Institute for Human Tissue Restoration, Yonsei University College of Medicine, Seoul, Korea
| | - Yun Rak Choi
- Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, Korea
- Organ Transplantation Center, Severance Hospital, Seoul, Korea
| | - Dong Jin Joo
- Organ Transplantation Center, Severance Hospital, Seoul, Korea
- Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
- The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea
| | - Woo Yeol Baek
- Department of Plastic & Reconstructive Surgery, Yonsei University College of Medicine, Seoul, Korea
- Institute for Human Tissue Restoration, Yonsei University College of Medicine, Seoul, Korea
| | - Young Chul Suh
- Department of Plastic & Reconstructive Surgery, Yonsei University College of Medicine, Seoul, Korea
- Institute for Human Tissue Restoration, Yonsei University College of Medicine, Seoul, Korea
| | - Won Taek Oh
- Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, Korea
| | - Jae Yong Cho
- Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, Korea
| | - Sang Chul Lee
- Department of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Korea
| | - Sang Kyum Kim
- Department of Diagnostic Pathology, Yonsei University College of Medicine, Seoul, Korea
| | - Hyang Joo Ryu
- Department of Diagnostic Pathology, Yonsei University College of Medicine, Seoul, Korea
| | - Kyung Ock Jeon
- Organ Transplantation Center, Severance Hospital, Seoul, Korea
| | - Won Jai Lee
- Department of Plastic & Reconstructive Surgery, Yonsei University College of Medicine, Seoul, Korea
- Institute for Human Tissue Restoration, Yonsei University College of Medicine, Seoul, Korea
| | - Jong Won Hong
- Department of Plastic & Reconstructive Surgery, Yonsei University College of Medicine, Seoul, Korea
- Institute for Human Tissue Restoration, Yonsei University College of Medicine, Seoul, Korea
- Organ Transplantation Center, Severance Hospital, Seoul, Korea.
| |
Collapse
|
4
|
Pak A, Zylstra AB, Baker KL, Casey DT, Dewald E, Divol L, Hohenberger M, Moore AS, Ralph JE, Schlossberg DJ, Tommasini R, Aybar N, Bachmann B, Bionta RM, Fittinghoff D, Gatu Johnson M, Geppert Kleinrath H, Geppert Kleinrath V, Hahn KD, Rubery MS, Landen OL, Moody JD, Aghaian L, Allen A, Baxamusa SH, Bhandarkar SD, Biener J, Birge NW, Braun T, Briggs TM, Choate C, Clark DS, Crippen JW, Danly C, Döppner T, Durocher M, Erickson M, Fehrenbach T, Freeman M, Havre M, Hayes S, Hilsabeck T, Holder JP, Humbird KD, Hurricane OA, Izumi N, Kerr SM, Khan SF, Kim YH, Kong C, Jeet J, Kozioziemski B, Kritcher AL, Lamb KM, Lemos NC, MacGowan BJ, Mackinnon AJ, MacPhee AG, Marley EV, Meaney K, Millot M, Di Nicola JMG, Nikroo A, Nora R, Ratledge M, Ross JS, Shin SJ, Smalyuk VA, Stadermann M, Stoupin S, Suratwala T, Trosseille C, Van Wonterghem B, Weber CR, Wild C, Wilde C, Wooddy PT, Woodworth BN, Young CV. Observations and properties of the first laboratory fusion experiment to exceed a target gain of unity. Phys Rev E 2024; 109:025203. [PMID: 38491694 DOI: 10.1103/physreve.109.025203] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2023] [Accepted: 01/18/2024] [Indexed: 03/18/2024]
Abstract
An indirect-drive inertial fusion experiment on the National Ignition Facility was driven using 2.05 MJ of laser light at a wavelength of 351 nm and produced 3.1±0.16 MJ of total fusion yield, producing a target gain G=1.5±0.1 exceeding unity for the first time in a laboratory experiment [Phys. Rev. E 109, 025204 (2024)10.1103/PhysRevE.109.025204]. Herein we describe the experimental evidence for the increased drive on the capsule using additional laser energy and control over known degradation mechanisms, which are critical to achieving high performance. Improved fuel compression relative to previous megajoule-yield experiments is observed. Novel signatures of the ignition and burn propagation to high yield can now be studied in the laboratory for the first time.
Collapse
Affiliation(s)
- A Pak
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - A B Zylstra
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - K L Baker
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - D T Casey
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - E Dewald
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - L Divol
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - M Hohenberger
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - A S Moore
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - J E Ralph
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - D J Schlossberg
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - R Tommasini
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - N Aybar
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - B Bachmann
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - R M Bionta
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - D Fittinghoff
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - M Gatu Johnson
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - H Geppert Kleinrath
- Los Alamos National Laboratory, Mail Stop F663, Los Alamos, New Mexico 87545, USA
| | - V Geppert Kleinrath
- Los Alamos National Laboratory, Mail Stop F663, Los Alamos, New Mexico 87545, USA
| | - K D Hahn
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - M S Rubery
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - O L Landen
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - J D Moody
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - L Aghaian
- General Atomics, San Diego, California 92186, USA
| | - A Allen
- General Atomics, San Diego, California 92186, USA
| | - S H Baxamusa
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - S D Bhandarkar
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - J Biener
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - N W Birge
- Los Alamos National Laboratory, Mail Stop F663, Los Alamos, New Mexico 87545, USA
| | - T Braun
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - T M Briggs
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - C Choate
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - D S Clark
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - J W Crippen
- General Atomics, San Diego, California 92186, USA
| | - C Danly
- Los Alamos National Laboratory, Mail Stop F663, Los Alamos, New Mexico 87545, USA
| | - T Döppner
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - M Durocher
- Los Alamos National Laboratory, Mail Stop F663, Los Alamos, New Mexico 87545, USA
| | - M Erickson
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | | | - M Freeman
- Los Alamos National Laboratory, Mail Stop F663, Los Alamos, New Mexico 87545, USA
| | - M Havre
- General Atomics, San Diego, California 92186, USA
| | - S Hayes
- General Atomics, San Diego, California 92186, USA
| | - T Hilsabeck
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - J P Holder
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - K D Humbird
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - O A Hurricane
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - N Izumi
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - S M Kerr
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - S F Khan
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - Y H Kim
- Los Alamos National Laboratory, Mail Stop F663, Los Alamos, New Mexico 87545, USA
| | - C Kong
- General Atomics, San Diego, California 92186, USA
| | - J Jeet
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - B Kozioziemski
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - A L Kritcher
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - K M Lamb
- Los Alamos National Laboratory, Mail Stop F663, Los Alamos, New Mexico 87545, USA
| | - N C Lemos
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - B J MacGowan
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - A J Mackinnon
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - A G MacPhee
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - E V Marley
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - K Meaney
- Los Alamos National Laboratory, Mail Stop F663, Los Alamos, New Mexico 87545, USA
| | - M Millot
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - J-M G Di Nicola
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - A Nikroo
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - R Nora
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - M Ratledge
- General Atomics, San Diego, California 92186, USA
| | - J S Ross
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - S J Shin
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - V A Smalyuk
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - M Stadermann
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - S Stoupin
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - T Suratwala
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - C Trosseille
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - B Van Wonterghem
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - C R Weber
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - C Wild
- Diamond Materials GmbH, 79108 Freiburg, Germany
| | - C Wilde
- Los Alamos National Laboratory, Mail Stop F663, Los Alamos, New Mexico 87545, USA
| | - P T Wooddy
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - B N Woodworth
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| | - C V Young
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, California 94551-0808, USA
| |
Collapse
|
5
|
Zanon I, Clément E, Goasduff A, Menéndez J, Miyagi T, Assié M, Ciemała M, Flavigny F, Lemasson A, Matta A, Ramos D, Rejmund M, Achouri L, Ackermann D, Barrientos D, Beaumel D, Benzoni G, Boston AJ, Boston HC, Bottoni S, Bracco A, Brugnara D, de France G, de Sereville N, Delaunay F, Desesquelles P, Didierjean F, Domingo-Prato C, Dudouet J, Eberth J, Fernández D, Fougères C, Gadea A, Galtarossa F, Girard-Alcindor V, Gonzales V, Gottardo A, Hammache F, Harkness-Brennan LJ, Hess H, Judson DS, Jungclaus A, Kaşkaş A, Kim YH, Kuşoğlu A, Labiche M, Leblond S, Lenain C, Lenzi SM, Leoni S, Li H, Ljungvall J, Lois-Fuentes J, Lopez-Martens A, Maj A, Menegazzo R, Mengoni D, Michelagnoli C, Million B, Napoli DR, Nyberg J, Pasqualato G, Podolyak Z, Pullia A, Quintana B, Recchia F, Regueira-Castro D, Reiter P, Rezynkina K, Rojo JS, Salsac MD, Sanchis E, Şenyiğit M, Siciliano M, Sohler D, Stezowski O, Theisen C, Utepov A, Valiente-Dobón JJ, Verney D, Zielinska M. High-Precision Spectroscopy of ^{20}O Benchmarking Ab Initio Calculations in Light Nuclei. Phys Rev Lett 2023; 131:262501. [PMID: 38215380 DOI: 10.1103/physrevlett.131.262501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Revised: 09/18/2023] [Accepted: 11/21/2023] [Indexed: 01/14/2024]
Abstract
The excited states of unstable ^{20}O were investigated via γ-ray spectroscopy following the ^{19}O(d,p)^{20}O reaction at 8 AMeV. By exploiting the Doppler shift attenuation method, the lifetimes of the 2_{2}^{+} and 3_{1}^{+} states were firmly established. From the γ-ray branching and E2/M1 mixing ratios for transitions deexciting the 2_{2}^{+} and 3_{1}^{+} states, the B(E2) and B(M1) were determined. Various chiral effective field theory Hamiltonians, describing the nuclear properties beyond ground states, along with a standard USDB interaction, were compared with the experimentally obtained data. Such a comparison for a large set of γ-ray transition probabilities with the valence space in medium similarity renormalization group ab initio calculations was performed for the first time in a nucleus far from stability. It was shown that the ab initio approaches using chiral effective field theory forces are challenged by detailed high-precision spectroscopic properties of nuclei. The reduced transition probabilities were found to be a very constraining test of the performance of the ab initio models.
Collapse
Affiliation(s)
- I Zanon
- INFN Laboratori Nazionali di Legnaro, Legnaro, Italy
- Dipartimento di Fisica e Scienze della Terra, Università di Ferrara, Ferrara, Italy
| | - E Clément
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
| | - A Goasduff
- INFN Laboratori Nazionali di Legnaro, Legnaro, Italy
| | - J Menéndez
- Department of Quantum Physics and Astrophysics and Institute of Cosmos Sciences, University of Barcelona, Spain
| | - T Miyagi
- Department of Physics, Technische Universität Darmstadt, Darmstadt, Germany
- ExtreMe Matter Institute, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
- Max-Planck-Institut für Kernphysik, Heidelberg, Germany
| | - M Assié
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | | | - F Flavigny
- Université de Caen Normandie, ENSICAEN, CNRS/IN2P3, LPC Caen UMR6534, F-14000 Caen, France
| | - A Lemasson
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
| | - A Matta
- Université de Caen Normandie, ENSICAEN, CNRS/IN2P3, LPC Caen UMR6534, F-14000 Caen, France
| | - D Ramos
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
| | - M Rejmund
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
| | - L Achouri
- Université de Caen Normandie, ENSICAEN, CNRS/IN2P3, LPC Caen UMR6534, F-14000 Caen, France
| | - D Ackermann
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
| | | | - D Beaumel
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G Benzoni
- INFN Sezione di Milano, I-20133 Milano, Italy
| | - A J Boston
- Oliver Lodge Laboratory, The University of Liverpool, Liverpool, United Kingdom
| | - H C Boston
- Oliver Lodge Laboratory, The University of Liverpool, Liverpool, United Kingdom
| | - S Bottoni
- INFN Sezione di Milano, I-20133 Milano, Italy
- Dipartimento di Fisica, Università di Milano, Milano, Italy
| | - A Bracco
- INFN Sezione di Milano, I-20133 Milano, Italy
- Dipartimento di Fisica, Università di Milano, Milano, Italy
| | - D Brugnara
- INFN Laboratori Nazionali di Legnaro, Legnaro, Italy
- Dipartimento di Fisica, Università di Padova, Padova, Italy
| | - G de France
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
| | - N de Sereville
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - F Delaunay
- Université de Caen Normandie, ENSICAEN, CNRS/IN2P3, LPC Caen UMR6534, F-14000 Caen, France
| | - P Desesquelles
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - F Didierjean
- Université de Strasbourg, IPHC, Strasbourg, France
| | - C Domingo-Prato
- Instituto de Fisica Corpuscolar, CSIC-Universidad de Valencia, E-46071 Valencia, Spain
| | - J Dudouet
- Université de Lyon, Université Lyon-1, CNRS/IN2P3, UMR5822, IP2I, F-69622 Villeurbanne Cedex, France
| | - J Eberth
- Institut für Kernphysik, Universität zu Köln, Zülpicher Strasse 77, D-50937 Köln, Germany
| | - D Fernández
- IGFAE and Department de Física de Partículas, Universidade of Santiago de Compostela, Santiago de Compostela, Spain
| | - C Fougères
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
| | - A Gadea
- Instituto de Fisica Corpuscolar, CSIC-Universidad de Valencia, E-46071 Valencia, Spain
| | - F Galtarossa
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Girard-Alcindor
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
| | - V Gonzales
- Departamento de Ingeniería Electrónica, Universitat de Valencia, Burjassot, Valencia, Spain
| | - A Gottardo
- INFN Laboratori Nazionali di Legnaro, Legnaro, Italy
| | - F Hammache
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | | | - H Hess
- Institut für Kernphysik, Universität zu Köln, Zülpicher Strasse 77, D-50937 Köln, Germany
| | - D S Judson
- Oliver Lodge Laboratory, The University of Liverpool, Liverpool, United Kingdom
| | - A Jungclaus
- Instituto de Estructura de la Materia, CSIC, Madrid, E-28006 Madrid, Spain
| | - A Kaşkaş
- Department of Physics, Faculty of Science, Ankara University, 06100 Besevler - Ankara, Turkey
| | - Y H Kim
- Institue Laue-Langevin, Grenoble, France
| | - A Kuşoğlu
- Department of Physics, Faculty of Science, Istanbul University, Vezneciler/Fatih, Istanbul, Turkey
| | - M Labiche
- STFC Daresbury Laboratory, Daresbury, Warrington, WA4 4AD, United Kingdom
| | - S Leblond
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
| | - C Lenain
- Université de Caen Normandie, ENSICAEN, CNRS/IN2P3, LPC Caen UMR6534, F-14000 Caen, France
| | - S M Lenzi
- INFN, Sezione di Padova, I-35131 Padova, Italy
| | - S Leoni
- INFN Sezione di Milano, I-20133 Milano, Italy
| | - H Li
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
| | - J Ljungvall
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - J Lois-Fuentes
- IGFAE and Department de Física de Partículas, Universidade of Santiago de Compostela, Santiago de Compostela, Spain
| | - A Lopez-Martens
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A Maj
- The Henryk Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences, 31-342 Kraków, Poland
| | - R Menegazzo
- INFN, Sezione di Padova, I-35131 Padova, Italy
| | - D Mengoni
- Dipartimento di Fisica, Università di Padova, Padova, Italy
- INFN, Sezione di Padova, I-35131 Padova, Italy
| | - C Michelagnoli
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
- Institue Laue-Langevin, Grenoble, France
| | - B Million
- INFN Sezione di Milano, I-20133 Milano, Italy
| | - D R Napoli
- INFN Laboratori Nazionali di Legnaro, Legnaro, Italy
| | - J Nyberg
- Department of Physics and Astronomy, Uppsala University, SE-75120 Uppsala, Sweden
| | - G Pasqualato
- Dipartimento di Fisica, Università di Padova, Padova, Italy
- INFN, Sezione di Padova, I-35131 Padova, Italy
| | - Zs Podolyak
- Department of Physics, University of Surrey, Guildford, GU2 7XH, United Kingdom
| | - A Pullia
- INFN Sezione di Milano, I-20133 Milano, Italy
| | - B Quintana
- Laboratorio de Radiaciones Ionizantes, Departamento de Física Fundamental, Universidad de Salamanca, E-37008 Salamanca, Spain
| | - F Recchia
- Dipartimento di Fisica, Università di Padova, Padova, Italy
- INFN, Sezione di Padova, I-35131 Padova, Italy
| | - D Regueira-Castro
- IGFAE and Department de Física de Partículas, Universidade of Santiago de Compostela, Santiago de Compostela, Spain
| | - P Reiter
- Institut für Kernphysik, Universität zu Köln, Zülpicher Strasse 77, D-50937 Köln, Germany
| | - K Rezynkina
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - J S Rojo
- Department of Physics, University of York, York, United Kingdom
| | - M D Salsac
- Irfu, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - E Sanchis
- Departamento de Ingeniería Electrónica, Universitat de Valencia, Burjassot, Valencia, Spain
| | - M Şenyiğit
- Department of Physics, Faculty of Science, Ankara University, 06100 Besevler - Ankara, Turkey
| | - M Siciliano
- Irfu, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- Physics Division, Argonne National Laboratory, Lemont, Illinois 60439, USA
| | - D Sohler
- Institute for Nuclear Research, Atomki, 4001 Debrecen, Hungary
| | - O Stezowski
- Université de Lyon, Université Lyon-1, CNRS/IN2P3, UMR5822, IP2I, F-69622 Villeurbanne Cedex, France
| | - Ch Theisen
- Irfu, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Utepov
- Grand Accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Caen, France
- Université de Caen Normandie, ENSICAEN, CNRS/IN2P3, LPC Caen UMR6534, F-14000 Caen, France
| | | | - D Verney
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Zielinska
- Irfu, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| |
Collapse
|
6
|
Kim YH, Jeong H, Won BR, Jeon H, Park CH, Park D, Kim Y, Lee S, Myung JH. Nanoparticle Exsolution on Perovskite Oxides: Insights into Mechanism, Characteristics and Novel Strategies. Nanomicro Lett 2023; 16:33. [PMID: 38015283 PMCID: PMC10684483 DOI: 10.1007/s40820-023-01258-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Accepted: 10/19/2023] [Indexed: 11/29/2023]
Abstract
Supported nanoparticles have attracted considerable attention as a promising catalyst for achieving unique properties in numerous applications, including fuel cells, chemical conversion, and batteries. Nanocatalysts demonstrate high activity by expanding the number of active sites, but they also intensify deactivation issues, such as agglomeration and poisoning, simultaneously. Exsolution for bottom-up synthesis of supported nanoparticles has emerged as a breakthrough technique to overcome limitations associated with conventional nanomaterials. Nanoparticles are uniformly exsolved from perovskite oxide supports and socketed into the oxide support by a one-step reduction process. Their uniformity and stability, resulting from the socketed structure, play a crucial role in the development of novel nanocatalysts. Recently, tremendous research efforts have been dedicated to further controlling exsolution particles. To effectively address exsolution at a more precise level, understanding the underlying mechanism is essential. This review presents a comprehensive overview of the exsolution mechanism, with a focus on its driving force, processes, properties, and synergetic strategies, as well as new pathways for optimizing nanocatalysts in diverse applications.
Collapse
Affiliation(s)
- Yo Han Kim
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea
| | - Hyeongwon Jeong
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea
| | - Bo-Ram Won
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea
| | - Hyejin Jeon
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea
| | - Chan-Ho Park
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea
| | - Dayoung Park
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea
| | - Yeeun Kim
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea
| | - Somi Lee
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea
| | - Jae-Ha Myung
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea.
| |
Collapse
|
7
|
Adhikari G, Carlin N, Choi JJ, Choi S, Ezeribe AC, França LE, Ha C, Hahn IS, Hollick SJ, Jeon EJ, Jo JH, Joo HW, Kang WG, Kauer M, Kim BH, Kim HJ, Kim J, Kim KW, Kim SH, Kim SK, Kim WK, Kim YD, Kim YH, Ko YJ, Lee DH, Lee EK, Lee H, Lee HS, Lee HY, Lee IS, Lee J, Lee JY, Lee MH, Lee SH, Lee SM, Lee YJ, Leonard DS, Luan NT, Manzato BB, Maruyama RH, Neal RJ, Nikkel JA, Olsen SL, Park BJ, Park HK, Park HS, Park KS, Park SD, Pitta RLC, Prihtiadi H, Ra SJ, Rott C, Shin KA, Cavalcante DFFS, Scarff A, Spooner NJC, Thompson WG, Yang L, Yu GH. Search for Boosted Dark Matter in COSINE-100. Phys Rev Lett 2023; 131:201802. [PMID: 38039466 DOI: 10.1103/physrevlett.131.201802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2023] [Accepted: 10/30/2023] [Indexed: 12/03/2023]
Abstract
We search for energetic electron recoil signals induced by boosted dark matter (BDM) from the galactic center using the COSINE-100 array of NaI(Tl) crystal detectors at the Yangyang Underground Laboratory. The signal would be an excess of events with energies above 4 MeV over the well-understood background. Because no excess of events are observed in a 97.7 kg·yr exposure, we set limits on BDM interactions under a variety of hypotheses. Notably, we explored the dark photon parameter space, leading to competitive limits compared to direct dark photon search experiments, particularly for dark photon masses below 4 MeV and considering the invisible decay mode. Furthermore, by comparing our results with a previous BDM search conducted by the Super-Kamionkande experiment, we found that the COSINE-100 detector has advantages in searching for low-mass dark matter. This analysis demonstrates the potential of the COSINE-100 detector to search for MeV electron recoil signals produced by the dark sector particle interactions.
Collapse
Affiliation(s)
- G Adhikari
- Department of Physics and Wright Laboratory, Yale University, New Haven, Connecticut 06520, USA
| | - N Carlin
- Physics Institute, University of São Paulo, 05508-090, São Paulo, Brazil
| | - J J Choi
- Department of Physics and Astronomy, Seoul National University, Seoul 08826, Republic of Korea
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - S Choi
- Department of Physics and Astronomy, Seoul National University, Seoul 08826, Republic of Korea
| | - A C Ezeribe
- Department of Physics and Astronomy, University of Sheffield, Sheffield S3 7RH, United Kingdom
| | - L E França
- Physics Institute, University of São Paulo, 05508-090, São Paulo, Brazil
| | - C Ha
- Department of Physics, Chung-Ang University, Seoul 06973, Republic of Korea
| | - I S Hahn
- Department of Science Education, Ewha Womans University, Seoul 03760, Republic of Korea
- Center for Exotic Nuclear Studies, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
- IBS School, University of Science and Technology (UST), Daejeon 34113, Republic of Korea
| | - S J Hollick
- Department of Physics and Wright Laboratory, Yale University, New Haven, Connecticut 06520, USA
| | - E J Jeon
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - J H Jo
- Department of Physics and Wright Laboratory, Yale University, New Haven, Connecticut 06520, USA
| | - H W Joo
- Department of Physics and Astronomy, Seoul National University, Seoul 08826, Republic of Korea
| | - W G Kang
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - M Kauer
- Department of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - B H Kim
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - H J Kim
- Department of Physics, Kyungpook National University, Daegu 41566, Republic of Korea
| | - J Kim
- Department of Physics, Chung-Ang University, Seoul 06973, Republic of Korea
| | - K W Kim
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - S H Kim
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - S K Kim
- Department of Physics and Astronomy, Seoul National University, Seoul 08826, Republic of Korea
| | - W K Kim
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
- IBS School, University of Science and Technology (UST), Daejeon 34113, Republic of Korea
| | - Y D Kim
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
- IBS School, University of Science and Technology (UST), Daejeon 34113, Republic of Korea
- Department of Physics, Sejong University, Seoul 05006, Republic of Korea
| | - Y H Kim
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
- IBS School, University of Science and Technology (UST), Daejeon 34113, Republic of Korea
- Korea Research Institute of Standards and Science, Daejeon 34113, Republic of Korea
| | - Y J Ko
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - D H Lee
- Department of Physics, Kyungpook National University, Daegu 41566, Republic of Korea
| | - E K Lee
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - H Lee
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
- IBS School, University of Science and Technology (UST), Daejeon 34113, Republic of Korea
| | - H S Lee
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
- IBS School, University of Science and Technology (UST), Daejeon 34113, Republic of Korea
| | - H Y Lee
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - I S Lee
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - J Lee
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - J Y Lee
- Department of Physics, Kyungpook National University, Daegu 41566, Republic of Korea
| | - M H Lee
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
- IBS School, University of Science and Technology (UST), Daejeon 34113, Republic of Korea
| | - S H Lee
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
- IBS School, University of Science and Technology (UST), Daejeon 34113, Republic of Korea
| | - S M Lee
- Department of Physics and Astronomy, Seoul National University, Seoul 08826, Republic of Korea
| | - Y J Lee
- Department of Physics, Chung-Ang University, Seoul 06973, Republic of Korea
| | - D S Leonard
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - N T Luan
- Department of Physics, Kyungpook National University, Daegu 41566, Republic of Korea
| | - B B Manzato
- Physics Institute, University of São Paulo, 05508-090, São Paulo, Brazil
| | - R H Maruyama
- Department of Physics and Wright Laboratory, Yale University, New Haven, Connecticut 06520, USA
| | - R J Neal
- Department of Physics and Astronomy, University of Sheffield, Sheffield S3 7RH, United Kingdom
| | - J A Nikkel
- Department of Physics and Wright Laboratory, Yale University, New Haven, Connecticut 06520, USA
| | - S L Olsen
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - B J Park
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
- IBS School, University of Science and Technology (UST), Daejeon 34113, Republic of Korea
| | - H K Park
- Department of Accelerator Science, Korea University, Sejong 30019, Republic of Korea
| | - H S Park
- Korea Research Institute of Standards and Science, Daejeon 34113, Republic of Korea
| | - K S Park
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - S D Park
- Department of Physics, Kyungpook National University, Daegu 41566, Republic of Korea
| | - R L C Pitta
- Physics Institute, University of São Paulo, 05508-090, São Paulo, Brazil
| | - H Prihtiadi
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - S J Ra
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - C Rott
- Department of Physics, Sungkyunkwan University, Suwon 16419, Republic of Korea
- Department of Physics and Astronomy, University of Utah, Salt Lake City, Utah 84112, USA
| | - K A Shin
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
| | - D F F S Cavalcante
- Physics Institute, University of São Paulo, 05508-090, São Paulo, Brazil
| | - A Scarff
- Department of Physics and Astronomy, University of Sheffield, Sheffield S3 7RH, United Kingdom
| | - N J C Spooner
- Department of Physics and Astronomy, University of Sheffield, Sheffield S3 7RH, United Kingdom
| | - W G Thompson
- Department of Physics and Wright Laboratory, Yale University, New Haven, Connecticut 06520, USA
| | - L Yang
- Department of Physics, University of California San Diego, La Jolla, California 92093, USA
| | - G H Yu
- Center for Underground Physics, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
- Department of Physics, Sungkyunkwan University, Suwon 16419, Republic of Korea
| |
Collapse
|
8
|
Kim YH, Kim YC. Development of metastatic lung adenocarcinoma in a twenty-year-old skin graft site on the scalp: A case report. Indian J Dermatol Venereol Leprol 2023; 0:1-2. [PMID: 38031680 DOI: 10.25259/ijdvl_518_2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2023] [Accepted: 09/17/2023] [Indexed: 12/01/2023]
Affiliation(s)
- Y H Kim
- Department of Dermatology, Ajou University Hospital, World Cup-ro, Suwon, Korea
| | - Y C Kim
- Department of Dermatology, Ajou University Hospital, World Cup-ro, Suwon, Korea
| |
Collapse
|
9
|
Ree J, Ko KC, Kim YH, Shin HK. Excitation of NH Stretching Modes in Aromatic Molecules: o-Toluidine and α-Methylbenzylamine. J Phys Chem B 2023; 127:7276-7282. [PMID: 37566790 DOI: 10.1021/acs.jpcb.3c03968] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/13/2023]
Abstract
Selectively excited o-toluidine and α-methylbenzylamine have been studied with quasi-classical trajectory procedures to determine the extent and timescales of intramolecular energy flow. The initial excitation is in the stretching mode of the para-CH bond, and its flow is initiated by interaction with an argon atom. Energy flow to the NH stretching mode is the dominant relaxation pathway, and its effectiveness is enhanced strongly by the methyl-NH interaction. Energy flow characteristics in both molecules are similar, but the flow is more effective in o-toluidine than in α-methylbenzylamine because the methyl group bonded to the benzene ring exerts stronger perturbation on the energy-flow pathway than the group bonded to the side chain. The relaxation of the initially excited CH completes on a timescale of several picoseconds, but the main part of energy flow to the NH occurs on a subpicosecond scale. In o-toluidine, carbon-carbon overtone modes lead to ring-CC bonds gaining and transporting more energy than high-frequency CH bonds, but they all gain far less energy than the NH stretching mode.
Collapse
Affiliation(s)
- J Ree
- Department of Chemistry Education, Chonnam National University, Gwangju 61186, Korea
| | - K C Ko
- Department of Chemistry Education, Chonnam National University, Gwangju 61186, Korea
| | - Y H Kim
- Department of Chemistry, Inha University, Incheon 22212, Korea
| | - H K Shin
- Department of Chemistry, University of Nevada, Reno, Nevada 89557, United States
| |
Collapse
|
10
|
Kim YH, Park MR, Kim SY, Kim MY, Kim KW, Sohn MH. Respiratory microbiome profiles are associated with distinct inflammatory phenotype and lung function in children with asthma. J Investig Allergol Clin Immunol 2023:0. [PMID: 37260034 DOI: 10.18176/jiaci.0918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023] Open
Abstract
BACKGROUND Respiratory microbiome studies have fostered our understanding of various phenotypes and endotypes of heterogeneous asthma. However, the relationship between the respiratory microbiome and clinical phenotypes in children with asthma remains unclear. We aimed to identify microbiome-driven clusters reflecting the clinical features of asthma and their dominant microbiotas in children with asthma. METHODS Induced sputum was collected from children with asthma, and microbiome profiles were generated via sequencing of the V3-V4 region of the 16S rRNA gene. Cluster analysis was performed using the partitioning around medoid clustering method. The dominant microbiota in each cluster was determined using the Linear Discriminant Effect Size analysis. Each cluster was analyzed for association among the dominant microbiota, clinical phenotype, and inflammatory cytokine. RESULTS Eighty-three children diagnosed with asthma were evaluated. Among four clusters reflecting the clinical characteristics of asthma, cluster 1, dominated by Haemophilus and Neisseria, demonstrated lower post-bronchodilator (BD) forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) than that in the other clusters and more mixed granulocytic asthma. Neisseria negatively correlated with pre-BD and post-BD FEV1/FVC. Haemophilus and Neisseria positively correlated with programmed death-ligand (PD-L)1. CONCLUSION To our knowledge, this study is the first to analyze the relationship between an unbiased microbiome-driven cluster and clinical phenotype in children with asthma. The cluster dominated by Haemophilus and Neisseria showed fixed airflow obstruction and mixed granulocytic asthma, which correlated with PD-L1 levels. Thus, microbiome-driven unbiased clustering can help identify new asthma phenotypes related to endotypes in childhood asthma.
Collapse
Affiliation(s)
- Y H Kim
- Department of Pediatrics, Gangnam Severance Hospital, Seoul
- Institute of Allergy, Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul
| | - M R Park
- Department of Pediatrics, Gangnam Severance Hospital, Seoul
- Institute of Allergy, Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul
| | - S Y Kim
- Institute of Allergy, Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul
- Department of Pediatrics, Severance Hospital, Seoul
| | - M Y Kim
- Institute of Allergy, Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul
- Department of Pediatrics, Yongin Severance Hospital, Yongin, Korea
| | - K W Kim
- Institute of Allergy, Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul
- Department of Pediatrics, Severance Hospital, Seoul
| | - M H Sohn
- Institute of Allergy, Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul
- Department of Pediatrics, Severance Hospital, Seoul
| |
Collapse
|
11
|
Choi SK, Chung HS, Ko HS, Gen Y, Kim SM, Shin JE, Kil KC, Kim YH, Wie JH, Jo YS. Hemorrhagic morbidity in nulliparous patients with placenta previa without placenta accrete spectrum disorders. Niger J Clin Pract 2023; 26:432-437. [PMID: 37203107 DOI: 10.4103/njcp.njcp_456_22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
Background Placental adhesion spectrum (PAS) is a disease in which the trophoblast invades the myometrium, and is a well-known high-risk condition associated with placental previa. Aim The morbidity of nulliparous women with placenta previa without PAS disorders is unknown. Patients and Methods The data from nulliparous women who underwent cesarean delivery were collected retrospectively. The women were dichotomized into malpresentation (MP) and placenta previa groups. The placenta previa group was categorized into previa (PS) and low-lying (LL) groups. When the placenta covers the internal cervical os, it is called placenta previa, when the placenta is near the cervical os, it is called the low-lying placenta. Their maternal hemorrhagic morbidity and neonatal outcomes were analyzed and adjusted using multivariate analysis based on univariate analysis. Results A total of 1269 women were enrolled: 781 women in the MP group and 488 women in the PP-LL group. Regarding packed red blood cell transfusion, PP and LL had adjusted odds ratio (aOR) of 14.7 (95% confidence interval (CI): 6.6 - 32.5), and 11.3 (95% CI: 4.9 - 26) during admission, and 51.2 (95% CI: 22.1 - 122.7) and 10.3 (95% CI: 3.9 - 26.6) during operation, respectively. For intensive care unit admission, PS and LL had aOR of 15.9 (95% CI: 6.5 - 39.1) and 3.5 (95% CI: 1.1 - 10.9), respectively. No women had cesarean hysterectomy, major surgical complications, or maternal death. Conclusion Despite placenta previa without PAS disorders, maternal hemorrhagic morbidity was significantly increased. Thus, our results highlight the need for resources for those women with evidence of placenta previa including a low-lying placenta, even if those women do not meet PAS disorder criteria. In addition, placenta previa without PAS disorder was not associated with critical maternal complications.
Collapse
Affiliation(s)
- S K Choi
- Department of Obstetrics and Gynaecology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - H S Chung
- Department of Anaesthesiology and Pain Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - H S Ko
- Department of Obstetrics and Gynaecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Y Gen
- Department of Obstetrics and Gynaecology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - S M Kim
- Department of Obstetrics and Gynaecology, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - J E Shin
- Department of Obstetrics and Gynaecology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - K C Kil
- Department of Obstetrics and Gynaecology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Y H Kim
- Department of Obstetrics and Gynaecology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - J H Wie
- Department of Obstetrics and Gynaecology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| | - Y S Jo
- Department of Obstetrics and Gynaecology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
| |
Collapse
|
12
|
Kim YH, Jeong H, Won BR, Myung JH. Exsolution Modeling and Control to Improve the Catalytic Activity of Nanostructured Electrodes. Adv Mater 2023; 35:e2208984. [PMID: 36691762 DOI: 10.1002/adma.202208984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/29/2022] [Revised: 01/17/2023] [Indexed: 06/17/2023]
Abstract
In situ exsolution for nanoscale electrode design has attracted considerable attention because of its promising activity and high stability. However, fundamental research on the mechanisms underlying particle growth remains insufficient. Herein, cation-diffusion-determined exsolution is presented using an analytical model based on classical nucleation and diffusion. In the designed perovskite system, the exsolution trend for particle growth is consistent with this diffusion model, which strongly depends on the initial cation concentration and reduction conditions. Based on the experimental and theoretical results, a highly Ni-doped anode and an electrochemical switching technique are employed to promote exsolution and overcome growth limitations. The optimal cell exhibits an outstanding maximum power density of 1.7 W cm-2 at 900 °C and shows no evident degradation when operating at 800 °C for 240 h under wet H2 . This study provides crucial insights into the developing and tuning of heterogeneous catalysts for energy-conversion applications.
Collapse
Affiliation(s)
- Yo Han Kim
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea
| | - Hyeongwon Jeong
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea
| | - Bo-Ram Won
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea
| | - Jae-Ha Myung
- Department of Materials Science and Engineering, Incheon National University, Incheon, 22012, Republic of Korea
| |
Collapse
|
13
|
Han S, Choi HY, Kim YH, Choi S, Kim S, Nam JY, Kim B, Song GS, Lim HS, Bae KS. Comparison of Pharmacodynamics between Tegoprazan and Dexlansoprazole Regarding Nocturnal Acid Breakthrough: A Randomized Crossover Study. Gut Liver 2023; 17:92-99. [PMID: 36317518 PMCID: PMC9840922 DOI: 10.5009/gnl220050] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/07/2022] [Revised: 06/17/2022] [Accepted: 06/29/2022] [Indexed: 01/14/2023] Open
Abstract
Background/Aims Tegoprazan, a novel potassium-competitive acid blocker, is expected to overcome the limitations of proton pump inhibitors and effectively control nocturnal acid breakthrough. To evaluate the pharmacodynamics of tegoprazan versus dexlansoprazole regarding nocturnal acid breakthrough in healthy subjects. Methods In a randomized, open-label, single-dose, balanced incomplete block crossover study, 24 healthy male volunteers were enrolled and randomized to receive oral tegoprazan (50, 100, or 200 mg) or dexlansoprazole (60 mg) during each of two administration periods, separated by a 7- to 10-day washout period. Blood samples were collected for pharmacokinetic parameter analysis; gastric monitoring was performed for pharmacodynamic parameter evaluation. Results All 24 subjects completed the study. Average maximum plasma concentration, area under the plasma concentration-time curve, and mean time with gastric pH >4 and pH >6 for tegoprazan demonstrated dose-dependent incremental increases. All the tegoprazan groups reached mean pH ≥4 within 2 hours, whereas the dexlansoprazole group required 7 hours after drug administration. Based on pharmacodynamic parameters up to 12 hours after evening dosing, 50, 100, and 200 mg of tegoprazan presented a stronger acid-suppressive effect than 60 mg of dexlansoprazole. Moreover, the dexlansoprazole group presented a comparable acid-suppressive effect with the tegoprazan groups 12 hours after dosing. Conclusions All the tegoprazan groups demonstrated a significantly faster onset of gastric pH increase and longer holding times above pH >4 and pH >6 up to 12 hours after evening dosing than the dexlansoprazole group.
Collapse
Affiliation(s)
- Sungpil Han
- Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - Hee Youn Choi
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Yo Han Kim
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - SeungChan Choi
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Seokuee Kim
- Clinical Development, HK inno.N Corp., Seoul, Korea
| | - Ji Yeon Nam
- Clinical Development, HK inno.N Corp., Seoul, Korea
| | - Bongtae Kim
- Clinical Development, HK inno.N Corp., Seoul, Korea
| | | | - Hyeong-Seok Lim
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Kyun-Seop Bae
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea,Corresponding AuthorKyun-Seop Bae, ORCIDhttps://orcid.org/0000-0001-7399-5879, E-mail
| |
Collapse
|
14
|
Seo SM, Kim SJ, Kwon O, Brilakis ES, Yoon YH, Lee KS, Kim TO, Lee PH, Kang SJ, Kim YH, Lee CW, Park SW, Lee SW. Intravascular ultrasound-guided optimization for chronic total occlusion-percutaneous coronary intervention with multiple drug-eluting stents. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Multiple stenting in the chronic total occlusion (CTO) lesions is frequently required, however associated with poorer clinical outcomes. It is demonstrated that intravascular ultrasound (IVUS)-guided CTO-percutaneous coronary intervention (PCI) is related to a lower risk of adverse clinical events.
Purpose
We aimed to evaluate the clinical impact of stent optimization under IVUS guidance for multiple stenting, comparing with single stenting.
Methods
A total of 916 patients receiving drug-eluting stent (DES) under IVUS guidance were classified into two groups (stent optimization and non-optimization) according to optimization criteria (an absolute expansion criteria; minimal stent area ≥4.9 mm2 and a relative expansion criteria; 80% of mean reference lumen area). Of total population, 314 patients (34.3%) were treated with single stent and 575 patients (62.7%) were treated with multiple stents, respectively. Ischemic-driven target-lesion revascularization (TLR)/reocclusion was evaluated.
Results
Under IVUS guidance, 316 patients (34.5%) met IVUS criteria for stent optimization The achieving rates were 53% in the single stent group and 24% in the multiple stents group, respectively, (p<0.001). During a median of 4.7 years, the multiple stent group showed a significantly higher TLR/reocclusion rate, compared with the single stent group (12.8% vs. 5.2%, adjusted hazard ratio [HR] 2.51, 95% confidence interval [CI] 1.20–5.25, p=0.01). (Figure 1) Meeting both the absolute and relative expansion criteria was associated with a significantly low rate of TLR/reocclusion rate (12.5% vs. 5.2%, adjusted HR 0.34, 95% CI: 0.15–0.79, p=0.01). Under IVUS-guidance, there was no significant difference between multiple stenting and single stenting in case of achieving the optimization criteria (6.5% vs. 4.2%, p=0.11), whereas non-optimization group in the patients with multiple stenting showed a significantly higher rate of TLR/reocclusion, compared with IVUS-optimization group in the patients with single stenting (14.5% vs. 4.2%, p=0.002). (Figure 2)
Conclusions
In CTO-PCI with DES, multiple stenting significantly increased the risk of TLR/reocclusion. IVUS-guided optimization for multiple stenting showed a comparable long-term risk of TLR/reocclusion to single stenting with IVUS optimization. Hence, achieving IVUS expansion criteria may help to reduce the risk of TLR/reocclusion in CTO-PCI with multiple DES overlapping.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- S M Seo
- Eunpyeoung St. Mary's Hospital, Division of Cardiology, Department of Internal Medicine , Seoul , Korea (Republic of)
| | - S J Kim
- Eunpyeoung St. Mary's Hospital, Division of Cardiology, Department of Internal Medicine , Seoul , Korea (Republic of)
| | - O Kwon
- Eunpyeoung St. Mary's Hospital, Division of Cardiology, Department of Internal Medicine , Seoul , Korea (Republic of)
| | - E S Brilakis
- Minneapolis Heart Institute Foundation , Minneapolis , United States of America
| | - Y H Yoon
- Sejong Chungnam National University Hospital , Sejong , Korea (Republic of)
| | - K S Lee
- Daejeon St. Mary's Hospital , Daejeon , Korea (Republic of)
| | - T O Kim
- Asan Medical Center , Seoul , Korea (Republic of)
| | - P H Lee
- Asan Medical Center , Seoul , Korea (Republic of)
| | - S J Kang
- Asan Medical Center , Seoul , Korea (Republic of)
| | - Y H Kim
- Asan Medical Center , Seoul , Korea (Republic of)
| | - C W Lee
- Asan Medical Center , Seoul , Korea (Republic of)
| | - S W Park
- Asan Medical Center , Seoul , Korea (Republic of)
| | - S W Lee
- Asan Medical Center , Seoul , Korea (Republic of)
| |
Collapse
|
15
|
Jeong J, Choi JI, Kim YG, Choi YY, Min KJ, Roh SY, Shim JM, Kim JS, Kim YH. Late ventricular potential for risk prediction of sudden cardiac death risk: a valuable tool or an unnecessary step? Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background/Introduction
Signal-averaged electrocardiography (SA-ECG) is a high-resolution electrocardiography that can detect late ventricular potential, which known to be a noninvasive tool for risk stratification of sudden cardiac death (SCD) by predicting reentrant ventricular tachyarrhythmia. There is a paucity of data with SA-ECG on SCD survivors without structural heart disease, whereas majority of previous studies had been focused on post myocardial infarction survivors.
Purpose
This study assessed the clinical utility of SA-ECG as a risk stratification modality for lethal arrhythmic event in patients at risk of SCD without definite structural heart disease.
Methods
Total 629 patients who experienced or had potential risk of SCD were studied with SA-ECG. Among them, 48 patients who were found to have significant structural heart disease were excluded, except arrhythmogenic right ventricular cardiomyopathy. Major arrhythmic event (MAE) was defined as composite of all-cause death, aborted SCD, and sustained VT during any time either before visit of clinic or during follow up period. Syncope and non-sustained VT was defined as non-major arrhythmic event. SA-ECG was defined positive when fulfilling three or more criterion: (1) unfiltered QRS duration ≥114ms, (2) filtered QRS duration ≥114ms, (3) duration of terminal QRS <40uV exceeding 40ms, and (4) root mean square voltage in the terminal 40ms of ≤20ms.
Results
Among total 581 patients, 145 patients with positive SA-ECG showed higher incidence of MAE compared to patients with negative SA-ECG (21.4% vs. 6.7%, OR 3.816 [95% CI 2.208–6.597], p<0.001, Table). As the number of positive SA-ECG criteria increases, incidence of MAE tended to increase sequentially, which was markedly noted from 2 positive to 3 positive criteria (10.7% to 20.8%, p<0.001, Figure). In particular, patient with inherited arrhythmia showed higher rate of positive late potential compared to those with non-inherited arrhythmia (51.0% vs. 19.3%, p<0.001).
Conclusion
This study showed that at least 3 out of 4 diagnostic criteria in SA-ECG can independently predict lethal arrhythmic events and the positive late potential was associated with lethal arrhythmic event that leads to SCD, suggesting risk prediction for SCD using SA-ECG in patients even without structural heart disease including inherited arrhythmias.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- J Jeong
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| | - J I Choi
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| | - Y G Kim
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| | - Y Y Choi
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| | - K J Min
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| | - S Y Roh
- Korea University Guro Hospital , Seoul , Korea (Democratic People's Republic of)
| | - J M Shim
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| | - J S Kim
- Korea University Ansan Hospital , Ansan , Korea (Democratic People's Republic of)
| | - Y H Kim
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| |
Collapse
|
16
|
Jeong J, Choi JI, Kim YG, Choi YY, Min KJ, Roh SY, Shim JM, Kim JS, Kim YH. Clinical role of genetic testing for overlapping between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background/Introduction
Brugada syndrome (BrS) and arrhythmogenic right ventricular cardiomyopathy (ARVC) are inherited arrhythmias that may predispose to sudden cardiac arrest. Although its pathogenetic mechanisms differ, overlapping features between BrS and ARVC have been demonstrated previously. However, it remains to be determined whether genetic testing for ARVC-related gene is needed in patients with BrS.
Purpose
This study is aimed to analyze genetic profiles of BrS patients using next generation sequencing (NGS) based multigene panel including ARVC related genes.
Methods
Patients who were confirmed as BrS or clinically suspected as BrS with type 2 or 3 Brugada pattern electrocardiography were studied. Genetic testing using NGS panels (Illumina Inc., San Diego, CA, USA) included 30 genetic variants associated with inherited arrhythmia and genetic cardiomyopathy.
Results
Among the total 119 patients from BrS registry, 63 patients were confirmed as BrS and 56 patients were clinically suspected as BrS without fulfilling diagnostic criteria. One-hundred-fourteen patients (95.8%) were male, and mean age of onset was 43.6 year-old. Genetic variants were identified in 25 of 42 patients who received genetic testing. Six out of 25 patients (24.0%) showed ARVC-related genotypes (2 PKP2, 1 DSG2, 1 TMEM43, 1 JUP, and 1 DSP) (Figure 1 and Table 1). None of the patients showed structural or electrocardiographic features that fulfill diagnostic criteria of ARVC. It is notable that ARVC-related genotypes were mostly frequently accounted for BrS patients, following SCN5A and SCN10A.
Conclusion
In the clinic setting, ARVC-related genetic variants were identified in significant proportion of BrS patients, supporting that genetic testing of ARVC-overlapping is needed. This study suggests that follow-up including imaging study should be considered in BrS patients with ARVC-related genotypes to monitor disease progression as ARVC.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- J Jeong
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| | - J I Choi
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| | - Y G Kim
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| | - Y Y Choi
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| | - K J Min
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| | - S Y Roh
- Korea University Guro Hospital , Seoul , Korea (Democratic People's Republic of)
| | - J M Shim
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| | - J S Kim
- Korea University Ansan Hospital , Ansan , Korea (Democratic People's Republic of)
| | - Y H Kim
- Korea University Anam Hospital , Seoul , Korea (Republic of)
| |
Collapse
|
17
|
Pérez-Vidal RM, Gadea A, Domingo-Pardo C, Gargano A, Valiente-Dobón JJ, Clément E, Lemasson A, Coraggio L, Siciliano M, Szilner S, Bast M, Braunroth T, Collado J, Corina A, Dewald A, Doncel M, Dudouet J, de France G, Fransen C, González V, Hüyük T, Jacquot B, John PR, Jungclaus A, Kim YH, Korichi A, Labiche M, Lenzi S, Li H, Ljungvall J, López-Martens A, Mengoni D, Michelagnoli C, Müller-Gatermann C, Napoli DR, Navin A, Quintana B, Ramos D, Rejmund M, Sanchis E, Simpson J, Stezowski O, Wilmsen D, Zielińska M, Boston AJ, Barrientos D, Bednarczyk P, Benzoni G, Birkenbach B, Boston HC, Bracco A, Cederwall B, Cullen DM, Didierjean F, Eberth J, Gottardo A, Goupil J, Harkness-Brennan LJ, Hess H, Judson DS, Kaşkaş A, Korten W, Leoni S, Menegazzo R, Million B, Nyberg J, Podolyak Z, Pullia A, Ralet D, Recchia F, Reiter P, Rezynkina K, Salsac MD, Şenyiğit M, Sohler D, Theisen C, Verney D. Evidence of Partial Seniority Conservation in the πg_{9/2} Shell for the N=50 Isotones. Phys Rev Lett 2022; 129:112501. [PMID: 36154392 DOI: 10.1103/physrevlett.129.112501] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/31/2021] [Revised: 02/08/2022] [Accepted: 07/29/2022] [Indexed: 06/16/2023]
Abstract
The reduced transition probabilities for the 4_{1}^{+}→2_{1}^{+} and 2_{1}^{+}→0_{1}^{+} transitions in ^{92}Mo and ^{94}Ru and for the 4_{1}^{+}→2_{1}^{+} and 6_{1}^{+}→4_{1}^{+} transitions in ^{90}Zr have been determined in this experiment making use of a multinucleon transfer reaction. These results have been interpreted on the basis of realistic shell-model calculations in the f_{5/2}, p_{3/2}, p_{1/2}, and g_{9/2} proton valence space. Only the combination of extensive lifetime information and large scale shell-model calculations allowed the extent of the seniority conservation in the N=50 g_{9/2} orbital to be understood. The conclusion is that seniority is largely conserved in the first πg_{9/2} orbital.
Collapse
Affiliation(s)
- R M Pérez-Vidal
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, Valencia E-46980, Spain
- INFN Laboratori Nazionali di Legnaro, I-35020 Legnaro, Italy
| | - A Gadea
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, Valencia E-46980, Spain
| | - C Domingo-Pardo
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, Valencia E-46980, Spain
| | - A Gargano
- INFN Complesso Universitario di Monte S. Angelo, Via Cintia, I-80126 Napoli, Italy
| | | | - E Clément
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
| | - A Lemasson
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
| | - L Coraggio
- INFN Complesso Universitario di Monte S. Angelo, Via Cintia, I-80126 Napoli, Italy
- Dipartimento di Matematica e Fisica, Università degli Studi della Campania "Luigi Vanvitelli", viale Abramo Lincoln 5, I-81100 Caserta, Italy
| | - M Siciliano
- Physics Division, Argonne National Laboratory, Lemont, 60439 Illinois, USA
| | - S Szilner
- Ruder Bošković Institute, 10000 Zagreb, Croatia
| | - M Bast
- Institut für Kernphysik, Universität zu Köln, D-50937 Köln, Germany
| | - T Braunroth
- Institut für Kernphysik, Universität zu Köln, D-50937 Köln, Germany
| | - J Collado
- Departamento de Ingeniería Electrónica, Universitat de Valencia, Burjassot, E-46100 Valencia, Spain
| | - A Corina
- Department of Chemistry, Simon Fraser University, Burnaby, British Columbia BC V5A 1S6, Canada
| | - A Dewald
- Institut für Kernphysik, Universität zu Köln, D-50937 Köln, Germany
| | - M Doncel
- Department of Physics, Stockholm University, SE-106 91 Stockholm, Sweden
| | - J Dudouet
- Université Lyon, Université Claude Bernard Lyon 1, CNRS/IN2P3, IP2I Lyon, F-69622 Villeurbanne, France
| | - G de France
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
| | - C Fransen
- Institut für Kernphysik, Universität zu Köln, D-50937 Köln, Germany
| | - V González
- Departamento de Ingeniería Electrónica, Universitat de Valencia, Burjassot, E-46100 Valencia, Spain
| | - T Hüyük
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, Valencia E-46980, Spain
- Instituto de Estructura de la Materia, CSIC, Madrid, E-28006 Madrid, Spain
| | - B Jacquot
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
| | - P R John
- Institut für Kernphysik, Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - A Jungclaus
- Instituto de Estructura de la Materia, CSIC, Madrid, E-28006 Madrid, Spain
| | - Y H Kim
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
- Institut Laue-Langevin, 71 Avenue des Martyrs, 38042 Grenoble, France
| | - A Korichi
- IJCLab Orsay, IN2P3-CNRS, Université Paris-Saclay and Université Paris-Sud, 91405 Orsay, France
| | - M Labiche
- STFC Daresbury Laboratory, Daresbury, Warrington WA4 4AD, United Kingdom
| | - S Lenzi
- Dipartimento di Fisica e Astronomia dell'Università di Padova, I-35131 Padova, Italy
- INFN Sezione di Padova, I-35131 Padova, Italy
| | - H Li
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
| | - J Ljungvall
- IJCLab Orsay, IN2P3-CNRS, Université Paris-Saclay and Université Paris-Sud, 91405 Orsay, France
| | - A López-Martens
- IJCLab Orsay, IN2P3-CNRS, Université Paris-Saclay and Université Paris-Sud, 91405 Orsay, France
| | - D Mengoni
- Dipartimento di Fisica e Astronomia dell'Università di Padova, I-35131 Padova, Italy
- INFN Sezione di Padova, I-35131 Padova, Italy
| | - C Michelagnoli
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
- Institut Laue-Langevin, 71 Avenue des Martyrs, 38042 Grenoble, France
| | - C Müller-Gatermann
- Physics Division, Argonne National Laboratory, Lemont, 60439 Illinois, USA
- Institut für Kernphysik, Universität zu Köln, D-50937 Köln, Germany
| | - D R Napoli
- INFN Laboratori Nazionali di Legnaro, I-35020 Legnaro, Italy
| | - A Navin
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
| | - B Quintana
- Laboratorio de Radiaciones Ionizantes, Universidad de Salamanca, E-37008 Salamanca, Spain
| | - D Ramos
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
| | - M Rejmund
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
| | - E Sanchis
- Departamento de Ingeniería Electrónica, Universitat de Valencia, Burjassot, E-46100 Valencia, Spain
| | - J Simpson
- STFC Daresbury Laboratory, Daresbury, Warrington WA4 4AD, United Kingdom
| | - O Stezowski
- Université Lyon, Université Claude Bernard Lyon 1, CNRS/IN2P3, IP2I Lyon, F-69622 Villeurbanne, France
| | - D Wilmsen
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
| | - M Zielińska
- Irfu, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A J Boston
- Oliver Lodge Laboratory, The University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | | | - P Bednarczyk
- The Henryk Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences, ul. Radzikowskiego 152, 31-342 Kraków, Poland
| | - G Benzoni
- INFN Sezione di Milano, I-20133 Milano, Italy
| | - B Birkenbach
- Institut für Kernphysik, Universität zu Köln, D-50937 Köln, Germany
| | - H C Boston
- Oliver Lodge Laboratory, The University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - A Bracco
- INFN Sezione di Milano, I-20133 Milano, Italy
- Dipartimento di Fisica, Università di Milano, I-20133 Milano, Italy
| | - B Cederwall
- Department of Physics, KTH Royal Institute of Technology, SE-10691 Stockholm, Sweden
| | - D M Cullen
- Nuclear Physics Group, Schuster Laboratory, University of Manchester, Manchester M13 9PL, United Kingdom
| | - F Didierjean
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - J Eberth
- Institut für Kernphysik, Universität zu Köln, D-50937 Köln, Germany
| | - A Gottardo
- INFN Laboratori Nazionali di Legnaro, I-35020 Legnaro, Italy
| | - J Goupil
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
| | - L J Harkness-Brennan
- Oliver Lodge Laboratory, The University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - H Hess
- Institut für Kernphysik, Universität zu Köln, D-50937 Köln, Germany
| | - D S Judson
- Oliver Lodge Laboratory, The University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - A Kaşkaş
- Department of Physics, Ankara University, 06100 Besevler-Ankara, Turkey
| | - W Korten
- Irfu, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Leoni
- INFN Sezione di Milano, I-20133 Milano, Italy
- Dipartimento di Fisica, Università di Milano, I-20133 Milano, Italy
| | - R Menegazzo
- INFN Sezione di Padova, I-35131 Padova, Italy
| | - B Million
- INFN Sezione di Milano, I-20133 Milano, Italy
| | - J Nyberg
- Department of Physics and Astronomy, Uppsala University, SE-75120 Uppsala, Sweden
| | - Zs Podolyak
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - A Pullia
- INFN Sezione di Milano, I-20133 Milano, Italy
- Dipartimento di Fisica, Università di Milano, I-20133 Milano, Italy
| | - D Ralet
- Grand Accélérateur National d'Ions Lourds, CEA/DRF-CNRS/IN2P3, F-14076 Caen cedex 5, France
| | - F Recchia
- Dipartimento di Fisica e Astronomia dell'Università di Padova, I-35131 Padova, Italy
- INFN Sezione di Padova, I-35131 Padova, Italy
| | - P Reiter
- Institut für Kernphysik, Universität zu Köln, D-50937 Köln, Germany
| | - K Rezynkina
- INFN Sezione di Padova, I-35131 Padova, Italy
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - M D Salsac
- Irfu, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - M Şenyiğit
- Department of Physics, Ankara University, 06100 Besevler-Ankara, Turkey
| | - D Sohler
- Institute for Nuclear Research, Atomki, 4001 Debrecen, P.O. Box 51, Hungary
| | - Ch Theisen
- Irfu, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - D Verney
- IJCLab Orsay, IN2P3-CNRS, Université Paris-Saclay and Université Paris-Sud, 91405 Orsay, France
| |
Collapse
|
18
|
Bagot M, Muller M, Kim YH, Ortiz-Romero PL, Zinzani PL, Beylot-Barry M, Dalle S, Jacobsen E, Combalia A, Huen A, Mehta-Shah N, Khodadoust MS, Viotti J, Paiva C, Porcu P. Lacutamab in patients with advanced mycosis fungoides according to KIR3DL2 expression: stage 1 results from the TELLOMAK phase 2 trial. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00590-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
19
|
Kim H, Kim K, Kim YH. Associations between mental illness and cancer: a systematic review and meta-analysis of observational studies. Eur Rev Med Pharmacol Sci 2022; 26:4997-5007. [PMID: 35916796 DOI: 10.26355/eurrev_202207_29286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
OBJECTIVE Considering the impact of mental illness and cancer on the society, the relationship between the two diseases should be assessed. This study aimed at determining the association between mental illness and cancer. MATERIALS AND METHODS The Embase and Medline databases were searched on October 21, 2020. Cohort, case-control, and cross-sectional studies were eligible for study inclusion. The Newcastle-Ottawa scale was used to qualitatively assess the risk of bias. Funnel plots were drawn to evaluate the risks of bias across the included studies. RESULTS We included 58 studies from 16 countries, incorporating approximately 30 national databases and 25 million individuals. Patients with psychiatric disorders did not show an increased risk of developing cancer. However, patients with cancer had a significantly increased risk of developing mental illness. The survival rates of patients with mental illness according to cancer occurrence and patients with cancer according to mental illness occurrence were significantly decreased. CONCLUSIONS Clinicians should conduct early screening to ensure that appropriate interventions for mental illness are administered in patients with cancer. Due to the high incidence of death in patients with mental illnesses due to unnatural causes, such as suicide, homicide, and accidents, clinicians should be aware of the importance of the treatment and management of these patients.
Collapse
Affiliation(s)
- H Kim
- Department of Laboratory Medicine, Pusan National University Hospital, Busan, Republic of Korea.
| | | | | |
Collapse
|
20
|
Kim YH, Yoon J, Jeong YH. Experimental study of the nozzle size effect on aerosol removal by pool scrubbing. Nuclear Engineering and Design 2021. [DOI: 10.1016/j.nucengdes.2021.111544] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
21
|
Park JH, Yoon JE, Kim YH, Kim Y, Park TJ, Kang HY. The potential skin lightening candidate, senolytic drug ABT263, for photoageing pigmentation. Br J Dermatol 2021; 186:740-742. [PMID: 34773647 DOI: 10.1111/bjd.20893] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2021] [Revised: 11/09/2021] [Accepted: 11/09/2021] [Indexed: 11/28/2022]
Abstract
Senescent cells accumulate in several tissues during ageing, including the skin, and contribute to the functional decline of the skin via the senescence-associated secretory phenotypes (SASPs) 1 . Due to the potential negative effects of SASPs during the ageing process, drugs that selectively target senescent cells or SASPs represent an important therapeutic strategy to delay skin ageing. The selective induction of cell death specifically to kill senescent cells using drugs, referred to as senolytics, is a main approach to achieve this strategy 2 .
Collapse
Affiliation(s)
- J H Park
- Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon, Korea.,Institution of Inflamm-aging translational research center, Ajou University School of Medicine, Suwon, Korea
| | - J E Yoon
- Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon, Korea.,Institution of Inflamm-aging translational research center, Ajou University School of Medicine, Suwon, Korea
| | - Y H Kim
- Department of Dermatology, Ajou University School of Medicine, Suwon, Korea
| | - Y Kim
- Institution of Inflamm-aging translational research center, Ajou University School of Medicine, Suwon, Korea.,Department of Dermatology, Ajou University School of Medicine, Suwon, Korea
| | - T J Park
- Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon, Korea.,Institution of Inflamm-aging translational research center, Ajou University School of Medicine, Suwon, Korea
| | - H Y Kang
- Institution of Inflamm-aging translational research center, Ajou University School of Medicine, Suwon, Korea.,Department of Dermatology, Ajou University School of Medicine, Suwon, Korea
| |
Collapse
|
22
|
Cho SG, Kim YH, Park HJ, Park KS, Kim JH, Ahn SJ, Bom HS. Prediction of radiation-related cardiotoxicity using F-18 FDG PET in non-small-cell lung cancer. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Radiation-related cardiotoxicity has been refocused nowadays as the follow-up was increased amomg the patients with advanced lung cancer. The early recognition of the occult cardiotoxicity enables the early intervention preventing clinically significant cardiac events or worsening of severity.
Purpose
We aim to search whether the F-18 fluorodeoxyglucose positron emission tomography (FDG PET) performed immediately after radiotherapy could predict the late cardiac events.
Methods
We retrospectively enrolled 133 patients with locally advanced, unresectable stage III NSCLC who underwent F-18 fluorodeoxyglucose positron emission tomography (FDG PET) immediately after CCRT for the response evaluation and survived at least for 6 months. Heart was recontoured according to the RTOG 0617 secondary analysis atlas for the dose volume analysis. Standardized uptake values (SUV) of the left ventricular myocardium were measured on FDG PET images. The patients were regularly followed up for the disease progression and complications. The primary end-point was the cardiac events grade ≥2 based on the Common Terminology Criteria for Adverse Events (version 5.0).
Results
FDG PET was performed at median interval of 11 days after CCRT. Fourty-two patients experienced cardiotoxicity during a median follow-up of 47 months (range, 12 – 123 months). In univariable analysis, mean heart dose, maximum SUV of the left ventricle (LV SUVmax), white blood cell count, and diabetes were associated with the risk of cardiotoxicity. In multivariable analysis, only higher mean heart dose (>11.1 Gy, hazard ratio 3.930 [95% confidence interval 1.933–7.988]; p=0.0002) and higher LV SUVmax (>12.84, 2.189 [1.162–4.124]; p=0.0152) were independently associated with increased risk of cardiotoxicity. In subgroup analyses, LV SUVmax remained predictive of cardiotoxicity among those with higher mean heart dose, but not among those with lower mean heart dose.
Conclusion
Early FDG PET after CCRT for NSCLC could predict the late cardiac events, especially in patients with high dose cardiac irradiation.
Funding Acknowledgement
Type of funding sources: Public Institution(s). Main funding source(s): This work was supported by a grant of the Basic Science Research Program through the National Research Foundation funded by the Ministry of Education, Republic of Korea (Principal Investigator: Sang-Geon Cho)
Collapse
Affiliation(s)
- S G Cho
- Chonnam National University Hospital, Nuclear Medicine, Gwangju, Korea (Republic of)
| | - Y H Kim
- Chonnam National University Hwasun Hospital, Radiation Oncology, Hwasun, Korea (Republic of)
| | - H J Park
- Chonnam National University Hwasun Hospital, Cardiololgy, Hwasun, Korea (Republic of)
| | - K S Park
- Chonnam National University Hospital, Nuclear Medicine, Gwangju, Korea (Republic of)
| | - J H Kim
- Chonnam National University Hospital, Nuclear Medicine, Gwangju, Korea (Republic of)
| | - S J Ahn
- Chonnam National University Hwasun Hospital, Radiation Oncology, Hwasun, Korea (Republic of)
| | - H S Bom
- Chonnam National University Hwasun Hospital, Nuclear Medicine, Hwasun, Korea (Republic of)
| |
Collapse
|
23
|
Mizuguchi H, Kizaki K, Kimura A, Kushibiki S, Ikuta K, Kim YH, Sato S. Anti-lipopolysaccharide antibody mitigates ruminal lipopolysaccharide release without acute-phase inflammation or liver transcriptomic responses in Holstein bulls. J Vet Sci 2021; 22:e34. [PMID: 34056875 PMCID: PMC8170223 DOI: 10.4142/jvs.2021.22.e34] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Revised: 03/10/2021] [Accepted: 03/19/2021] [Indexed: 11/20/2022] Open
Abstract
Anti-lipopolysaccharide (LPS) antibody administration has the potential benefits of neutralizing and consequently controlling rumen-derived LPS during subacute ruminal acidosis. Four Holstein bulls were used in this crossover study with a 2-week wash-out period. Anti-LPS antibody (0 or 4 g) was administered once daily for 14 days. Significantly lower ruminal LPS and higher 1-h mean ruminal pH were identified in the 4 g group. However, blood metabolites, acute-phase proteins, cytokines, and hepatic transcriptomes were not different between the two groups. Therefore, anti-LPS antibody administration mitigated ruminal LPS release and pH depression without accompanying responses in acute-phase inflammation or hepatic transcriptomic expression.
Collapse
Affiliation(s)
| | - Keiichiro Kizaki
- Cooperative Department of Veterinary Medicine, Faculty of Agriculture, Iwate University, Morioka 020-8550, Japan
| | - Atsushi Kimura
- Cooperative Department of Veterinary Medicine, Faculty of Agriculture, Iwate University, Morioka 020-8550, Japan
| | - Shiro Kushibiki
- Institute of Livestock and Grassland Science, NARO, Tsukuba 305-0901, Japan
| | - Kentaro Ikuta
- Awaji Agricultural Technology Center, Minimi-Awaji 656-0442, Japan
| | - Yo Han Kim
- Cooperative Department of Veterinary Medicine, Faculty of Agriculture, Iwate University, Morioka 020-8550, Japan.,Department of Animal Resources Science, Dankook University, Cheonan 31116, Korea.
| | - Shigeru Sato
- Cooperative Department of Veterinary Medicine, Faculty of Agriculture, Iwate University, Morioka 020-8550, Japan.
| |
Collapse
|
24
|
Lotay G, Gillespie SA, Williams M, Rauscher T, Alcorta M, Amthor AM, Andreoiu CA, Baal D, Ball GC, Bhattacharjee SS, Behnamian H, Bildstein V, Burbadge C, Catford WN, Doherty DT, Esker NE, Garcia FH, Garnsworthy AB, Hackman G, Hallam S, Hudson KA, Jazrawi S, Kasanda E, Kennington ARL, Kim YH, Lennarz A, Lubna RS, Natzke CR, Nishimura N, Olaizola B, Paxman C, Psaltis A, Svensson CE, Williams J, Wallis B, Yates D, Walter D, Davids B. First Direct Measurement of an Astrophysical p-Process Reaction Cross Section Using a Radioactive Ion Beam. Phys Rev Lett 2021; 127:112701. [PMID: 34558922 DOI: 10.1103/physrevlett.127.112701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/14/2021] [Revised: 07/19/2021] [Accepted: 08/11/2021] [Indexed: 06/13/2023]
Abstract
We have performed the first direct measurement of the ^{83}Rb(p,γ) radiative capture reaction cross section in inverse kinematics using a radioactive beam of ^{83}Rb at incident energies of 2.4 and 2.7A MeV. The measured cross section at an effective relative kinetic energy of E_{cm}=2.393 MeV, which lies within the relevant energy window for core collapse supernovae, is smaller than the prediction of statistical model calculations. This leads to the abundance of ^{84}Sr produced in the astrophysical p process being higher than previously calculated. Moreover, the discrepancy of the present data with theoretical predictions indicates that further experimental investigation of p-process reactions involving unstable projectiles is clearly warranted.
Collapse
Affiliation(s)
- G Lotay
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - S A Gillespie
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - M Williams
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
- Department of Physics, University of York, Heslington, York YO10 5DD, United Kingdom
| | - T Rauscher
- Department of Physics, University of Basel, Klingelbergstrasse 82, CH-4056 Basel, Switzerland
- Centre for Astrophysics Research, University of Hertfordshire, Hatfield AL10 9AB, United Kingdom
| | - M Alcorta
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - A M Amthor
- Department of Physics and Astronomy, Bucknell University, Lewisburg, Pennsylvania 17837, USA
| | - C A Andreoiu
- Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada
| | - D Baal
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - G C Ball
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - S S Bhattacharjee
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - H Behnamian
- Department of Physics, University of Guelph, Guelph, Ontario N1G 2W1, Canada
| | - V Bildstein
- Department of Physics, University of Guelph, Guelph, Ontario N1G 2W1, Canada
| | - C Burbadge
- Department of Physics, University of Guelph, Guelph, Ontario N1G 2W1, Canada
| | - W N Catford
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - D T Doherty
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - N E Esker
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - F H Garcia
- Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada
| | - A B Garnsworthy
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - G Hackman
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - S Hallam
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - K A Hudson
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
- Department of Physics, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada
| | - S Jazrawi
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - E Kasanda
- Department of Physics, University of Guelph, Guelph, Ontario N1G 2W1, Canada
| | - A R L Kennington
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - Y H Kim
- Department of Nuclear Engineering, Hanyang University, Seoul 04763, Republic of Korea
| | - A Lennarz
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - R S Lubna
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - C R Natzke
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
- Department of Physics, Colorado School of Mines, Golden, Colorado 80401, USA
| | - N Nishimura
- Astrophysical Big Bang Laboratory, CPR, RIKEN, Wako, Saitama 351-0198, Japan
| | - B Olaizola
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - C Paxman
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - A Psaltis
- Department of Physics and Astronomy, McMaster University, Hamilton, Ontario L8S 4L8, Canada
| | - C E Svensson
- Department of Physics, University of Guelph, Guelph, Ontario N1G 2W1, Canada
| | - J Williams
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - B Wallis
- Department of Physics, University of York, Heslington, York YO10 5DD, United Kingdom
| | - D Yates
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
- Department of Physics and Astronomy, University of British Columbia, Vancouver BC V6T 1Z4, Canada
| | - D Walter
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
| | - B Davids
- TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada
- Department of Physics, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada
| |
Collapse
|
25
|
Martin WK, Padilla S, Kim YH, Hunter DL, Hays MD, DeMarini DM, Hazari MS, Gilmour MI, Farraj AK. Zebrafish irritant responses to wildland fire-related biomass smoke are influenced by fuel type, combustion phase, and byproduct chemistry. J Toxicol Environ Health A 2021; 84:674-688. [PMID: 34006202 PMCID: PMC8237130 DOI: 10.1080/15287394.2021.1925608] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
Human exposure to wildfire-derived particulate matter (PM) is linked to adverse health outcomes; however, little is known regarding the influence of biomass fuel type and burn conditions on toxicity. The aim of this study was to assess the irritant potential of extractable organic material (EOM) of biomass smoke condensates from five fuels (eucalyptus, pine, pine needle, peat, or red oak), representing various fire-prone regions of the USA, burned at two temperatures each [flaming (approximately 640°C) or (smoldering approximately 500°C)] using a locomotor assay in zebrafish (Danio rerio) larvae. It was postulated that locomotor responses, as measures of irritant effects, might be dependent upon fuel type and burn conditions and that these differences relate to combustion byproduct chemistry. To test this, locomotor activity was tracked for 60 min in 6-day-old zebrafish larvae (25-32/group) immediately after exposure to 0.4% dimethyl sulfoxide (DMSO) vehicle or EOM from the biomass smoke condensates (0.3-30 µg EOM/ml; half-log intervals). All EOM samples produced concentration-dependent irritant responses. Linear regression analysis to derive rank-order potency indicated that on a µg PM basis, flaming pine and eucalyptus were the most irritating. In contrast, on an emission-factor basis, which normalizes responses to the amount of PM produced/kg of fuel burned, smoldering smoke condensates induced greater irritant responses (>100-fold) than flaming smoke condensates, with smoldering pine being the most potent. Importantly, irritant responses significantly correlated with polycyclic aromatic hydrocarbon (PAH) content, but not with organic carbon or methoxyphenols. Data indicate that fuel type and burn condition influence the quantity and chemical composition of PM as well as toxicity.
Collapse
Affiliation(s)
- W Kyle Martin
- Curriculum in Toxicology and Environmental Medicine, UNC-Chapel Hill, USA
| | - S Padilla
- Biomolecular and Computational Toxicology Division, Us Epa, Rtp, NC, US
| | - Y H Kim
- Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC, US
| | - D L Hunter
- Biomolecular and Computational Toxicology Division, Us Epa, Rtp, NC, US
| | - M D Hays
- Air Methods & Characterization Division, Us Epa, Rtp, NC, US
| | - D M DeMarini
- Biomolecular and Computational Toxicology Division, Us Epa, Rtp, NC, US
| | - M S Hazari
- Public Health and Integrated Toxicology Division, Us Epa, Rtp, NC, US
| | - M I Gilmour
- Public Health and Integrated Toxicology Division, Us Epa, Rtp, NC, US
| | - A K Farraj
- Public Health and Integrated Toxicology Division, Us Epa, Rtp, NC, US
| |
Collapse
|
26
|
Han S, Choi HY, Kim YH, Nam JY, Kim B, Song GS, Lim HS, Bae KS. Effect of Food on the Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of Tegoprazan. Clin Ther 2021; 43:1371-1380. [PMID: 34246485 DOI: 10.1016/j.clinthera.2021.06.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2020] [Revised: 06/03/2021] [Accepted: 06/11/2021] [Indexed: 11/24/2022]
Abstract
PURPOSE Tegoprazan is a potassium-competitive acid blocker (P-CAB) that is designed to treat acid-related diseases through a fundamentally different mechanism than that of proton pump inhibitors (PPIs). Because PPIs inhibit only activated parietal cell H+/K+ adenosine triphosphatase, stimulation of parietal cells by a meal is necessary for optimal results. In contrast, P-CABs can inactivate proton pumps without acid activation and bind to both activated and inactivated adenosine triphosphatase. This study evaluates the effect of food consumption on the pharmacokinetic and pharmacodynamic properties of tegoprazan after a single oral dose in healthy men. METHODS In this open-label, 2-period crossover study, 24 healthy men were randomized to 1 of 2 treatment sequence groups: administration of tegoprazan under the fasting condition and administration of tegoprazan under the fed condition. The dosing periods of both sequence groups were separated by a washout period of 7 days. At each dosing period, the participants received a single dose of 200 mg of tegoprazan followed by pharmacokinetic and pharmacodynamic analysis. FINDINGS After the oral administration of 200 mg tegoprazan, the Cmax was decreased and delayed under the fed condition compared with that of the fasting condition. However, no significant differences were observed in the AUC and the time of gastric acid suppression (inhibition of integrated acidity) during 24 hours. IMPLICATIONS The pharmacokinetic and pharmacodynamic properties of tegoprazan are independent of food effect; thus, tegoprazan could be administered regardless of the timing of food consumption in patients. ClinicalTrials.gov identifier: NCT01830309.
Collapse
Affiliation(s)
- Sungpil Han
- Department of Clinical Pharmacology and Therapeutics, Seoul St. Mary's Hospital, Seoul, Korea; Pharmacometrics Institute for Practical Education and Training, Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - Hee Youn Choi
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan, Seoul, Korea
| | - Yo Han Kim
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan, Seoul, Korea
| | - Ji Yeon Nam
- Clinical Development Division, HK inno.N Corp, Seoul, Korea
| | - Bongtae Kim
- Clinical Development Division, HK inno.N Corp, Seoul, Korea
| | - Geun Seog Song
- Clinical Development Division, HK inno.N Corp, Seoul, Korea
| | - Hyeong-Seok Lim
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan, Seoul, Korea
| | - Kyun-Seop Bae
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan, Seoul, Korea.
| |
Collapse
|
27
|
Tsauo J, Noh SY, Shin JH, Gwon DI, Han K, Lee JM, Jeon UB, Kim YH. Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with hepatocellular carcinoma: a multicentre retrospective study. Clin Radiol 2021; 76:681-687. [PMID: 34140137 DOI: 10.1016/j.crad.2021.05.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2020] [Accepted: 05/14/2021] [Indexed: 12/14/2022]
Abstract
AIM To evaluate the effectiveness and safety of retrograde transvenous obliteration (RTO) for the prevention of variceal rebleeding variceal rebleeding in patients with hepatocellular carcinoma (HCC). MATERIALS AND METHODS This multicentre retrospective study enrolled 79 patients with HCC who underwent RTO for the prevention of variceal rebleeding. Successful occlusion of the gastrorenal shunt and obliteration of the gastric varices were achieved in 74 patients, with a technical success rate of 93.7%. Of the remaining 74 patients (mean age, 64.9±10.3 years; 56 men), 66 (90.4%) had gastroesophageal varices and seven (9.6%) had isolated gastric varices. Thirty-two patients (43.8%) underwent balloon-occluded RTO, 40 patients (54.8%) underwent plug-assisted RTO, and one patient (1.4%) underwent coil-assisted RTO. No patients had major procedural complications. RESULTS Rebleeding occurred in seven patients (9.6%) during the follow-up period. The 6-week and 1-year actuarial probabilities of patients remaining free of rebleeding were 90.8±3.6% and 88.6±4.1%, respectively. The median survival was 12.6 (95% confidence interval [CI] 8-17.3) months. The 6-week, 1-year, and 3-year actuarial probabilities of survival were 83.2±4.4%, 51.1±6.6%, and 32.7±7%, respectively. New or worsening ascites and oesophageal varices occurred in 12 (16.4%) and 13 patients (17.8%), respectively, during the follow-up period. Overt hepatic encephalopathy occurred in one patient (1.4%) during the follow-up period. The Child-Pugh score remained comparable to that at baseline at 1 and 3 months. CONCLUSION RTO was effective and safe in preventing variceal rebleeding in patients with HCC.
Collapse
Affiliation(s)
- J Tsauo
- Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - S Y Noh
- Department of Radiology, Kyung Hee University Seoul Hospital, Seoul, South Korea
| | - J H Shin
- Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
| | - D I Gwon
- Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - K Han
- Department of Radiology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
| | - J M Lee
- Department of Radiology, Soonchunhyang University Hospital, Bucheon, South Korea
| | - U B Jeon
- Department of Radiology, Pusan National University Yangsan Hospital, Yangsan, South Korea
| | - Y H Kim
- Department of Radiology, Daegu Catholic University Medical Center, Daegu, South Korea
| |
Collapse
|
28
|
Park JW, Kwon OS, Shim JM, Yu HT, Kim TH, Uhm JS, Kim JY, Choi JI, Joung BY, Lee MH, Kim YH, Pak HN. Artificial intelligence-predicted poor responders to catheter ablation for atrial fibrillation. Europace 2021. [DOI: 10.1093/europace/euab116.228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
Although atrial fibrillation (AF) catheter ablation is effective for rhythm control, in some patients it is hard to maintain sinus rhythm in spite of repeated AF catheter ablation (AFCA) procedures and anti-arrhythmic drugs (AADs). We explored the pre-procedural predictors for poor responders to AFCA and tested whether artificial intelligence (AI) assists the prediction of poor responders in the independent cohort by determining the invasive parameters.
Methods
Among 1,214 patients who underwent AFCA and regular rhythm follow-up for 56.2 ± 33.8 months (59 ± 11 years, 73.5% male, 68.6% paroxysmal AF), we differentiated 92 poor responders defined as those with sustained AF despite repeat AFCAs, AADs, or electrical cardioversion. Using the Youden index, we identified advanced LA remodeling with lower LA voltage under 1.109mV. AI model, which was derived from development cohort using medical record, was applied to predict LA voltage <1.109mV in the independent cohort (n = 634, poor responders = 24) using a grad-cam score.
Results
The patients with lower LA voltage under 1.109mV showed significantly poorer rhythm outcomes (Log-rank p < 0.001). We determined invasive parameter LA voltage by using the multiple variables (age, female sex, AF type, CHA2DS2VASc score, LA dimension, E/em, hemoglobin, PR interval) and achieved relatively good prediction power of AI for LA voltage <1.109mV (AUC = 0.734, sensitivity 0.729, specificity 0.643) in the test cohort. In the independent cohort, the AI model showed good discrimination power for poor responders (AUC 0.751, p < 0.001) by estimating LA voltage, which is an invasive variable. The patients with predicted lower LA voltage (grad-cam score <0) showed poorer rhythm outcome after active rhythm control (Log-rank p < 0.001)
Conclusions
The patients with advanced atrial remodeling with low LA voltage, which can be predicted by an AI, showed significantly higher recurrence of AF after AFCA with AADs or cardioversion. AI may assist to select these poor responder patients before the AFCA procedure. Abstract Figure.
Collapse
Affiliation(s)
- JW Park
- Yonsei University Health system, Seoul, Korea (Republic of)
| | - OS Kwon
- Yonsei University Health system, Seoul, Korea (Republic of)
| | - JM Shim
- Korea University, Cardiovascular Center, Seoul, Korea (Republic of)
| | - HT Yu
- Yonsei University Health system, Seoul, Korea (Republic of)
| | - TH Kim
- Yonsei University Health system, Seoul, Korea (Republic of)
| | - JS Uhm
- Yonsei University Health system, Seoul, Korea (Republic of)
| | - JY Kim
- Yonsei University Health system, Seoul, Korea (Republic of)
| | - JI Choi
- Korea University, Cardiovascular Center, Seoul, Korea (Republic of)
| | - BY Joung
- Yonsei University Health system, Seoul, Korea (Republic of)
| | - MH Lee
- Yonsei University Health system, Seoul, Korea (Republic of)
| | - YH Kim
- Korea University, Cardiovascular Center, Seoul, Korea (Republic of)
| | - HN Pak
- Yonsei University Health system, Seoul, Korea (Republic of)
| |
Collapse
|
29
|
Schmitt C, Lemasson A, Schmidt KH, Jhingan A, Biswas S, Kim YH, Ramos D, Andreyev AN, Curien D, Ciemala M, Clément E, Dorvaux O, De Canditiis B, Didierjean F, Duchêne G, Dudouet J, Frankland J, Jacquot B, Raison C, Ralet D, Retailleau BM, Stuttgé L, Tsekhanovich I. Experimental Evidence for Common Driving Effects in Low-Energy Fission from Sublead to Actinides. Phys Rev Lett 2021; 126:132502. [PMID: 33861122 DOI: 10.1103/physrevlett.126.132502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/19/2020] [Revised: 10/22/2020] [Accepted: 02/25/2021] [Indexed: 06/12/2023]
Abstract
Isotopic distributions of fragments from fission of the neutron-deficient ^{178}Hg nuclide are reported. This experimental observable is obtained for the first time in the region around lead using an innovative approach based on inverse kinematics and the coincidence between the large acceptance magnetic spectrometer VAMOS++ and a new detection arm close to the target. The average fragment N/Z ratio and prompt neutron M_{n} multiplicity are derived and compared with current knowledge from actinide fission. A striking consistency emerges, revealing the unexpected dominant role of the proton subsystem with atomic number between the Z=28 and 50 magic numbers. The origin of nuclear charge polarization in fission and fragment deformation at scission are discussed.
Collapse
Affiliation(s)
- C Schmitt
- Institut Pluridisciplinaire Hubert Curien, CNRS/IN2P3-UDS, 67037 Strasbourg Cedex 2, France
| | - A Lemasson
- GANIL, CEA/DRF-CNRS/IN2P3, BP 55027, 14076 Caen cedex 5, France
| | | | - A Jhingan
- Inter University Accelerator Centre, Aruna Asaf Ali Marg, Post Box 10502, New Delhi 110067, India
| | - S Biswas
- GANIL, CEA/DRF-CNRS/IN2P3, BP 55027, 14076 Caen cedex 5, France
| | - Y H Kim
- Institut Laue-Langevin, 38042 Grenoble Cedex 9, France
| | - D Ramos
- GANIL, CEA/DRF-CNRS/IN2P3, BP 55027, 14076 Caen cedex 5, France
| | - A N Andreyev
- Department of Physics, University of York, York YO10 5DD, United Kingdom
- Advanced Science Research Center, Japan Atomic Energy Agency, Tokai, Ibaraki 319-1195, Japan
- ISOLDE, CERN, CH-1211 Geneve 23, Switzerland
| | - D Curien
- Institut Pluridisciplinaire Hubert Curien, CNRS/IN2P3-UDS, 67037 Strasbourg Cedex 2, France
| | - M Ciemala
- The Niewodniczanski Institute of Nuclear Physics-PAN, 31-342 Kraków, Poland
| | - E Clément
- GANIL, CEA/DRF-CNRS/IN2P3, BP 55027, 14076 Caen cedex 5, France
| | - O Dorvaux
- Institut Pluridisciplinaire Hubert Curien, CNRS/IN2P3-UDS, 67037 Strasbourg Cedex 2, France
| | - B De Canditiis
- Institut Pluridisciplinaire Hubert Curien, CNRS/IN2P3-UDS, 67037 Strasbourg Cedex 2, France
| | - F Didierjean
- Institut Pluridisciplinaire Hubert Curien, CNRS/IN2P3-UDS, 67037 Strasbourg Cedex 2, France
| | - G Duchêne
- Institut Pluridisciplinaire Hubert Curien, CNRS/IN2P3-UDS, 67037 Strasbourg Cedex 2, France
| | - J Dudouet
- CSNSM, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, 91405 Orsay, France
- Université Lyon, Université Claude Bernard Lyon 1, CNRS/IN2P3, IP2I Lyon, UMR 5822, F-69622 Villeurbanne, France
| | - J Frankland
- GANIL, CEA/DRF-CNRS/IN2P3, BP 55027, 14076 Caen cedex 5, France
| | - B Jacquot
- GANIL, CEA/DRF-CNRS/IN2P3, BP 55027, 14076 Caen cedex 5, France
| | - C Raison
- Department of Physics, University of York, York YO10 5DD, United Kingdom
| | - D Ralet
- GANIL, CEA/DRF-CNRS/IN2P3, BP 55027, 14076 Caen cedex 5, France
| | - B-M Retailleau
- GANIL, CEA/DRF-CNRS/IN2P3, BP 55027, 14076 Caen cedex 5, France
| | - L Stuttgé
- Université Lyon, Université Claude Bernard Lyon 1, CNRS/IN2P3, IP2I Lyon, UMR 5822, F-69622 Villeurbanne, France
| | - I Tsekhanovich
- Université Bordeaux, CNRS, CENBG, UMR 5797, F-33170 Gradignan, France
| |
Collapse
|
30
|
Hodak E, Sherman S, Papadavid E, Bagot M, Querfeld C, Quaglino P, Prince HM, Ortiz-Romero PL, Stadler R, Knobler R, Guenova E, Estrach T, Patsatsi A, Leshem YA, Prague-Naveh H, Berti E, Alberti-Violetti S, Cowan R, Jonak C, Nikolaou V, Mitteldorf C, Akilov O, Geskin L, Matin R, Beylot-Barry M, Vakeva L, Sanches JA, Servitje O, Weatherhead S, Wobser M, Yoo J, Bayne M, Bates A, Dunnill G, Marschalko M, Buschots AM, Wehkamp U, Evison F, Hong E, Amitay-Laish I, Stranzenbach R, Vermeer M, Willemze R, Kempf W, Cerroni L, Whittaker S, Kim YH, Scarisbrick JJ. Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study. Br J Dermatol 2021; 184:524-531. [PMID: 32574377 DOI: 10.1111/bjd.19303] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/30/2020] [Indexed: 12/12/2022]
Abstract
BACKGROUND Early-stage mycosis fungoides (MF) includes involvement of dermatopathic lymph nodes (LNs) or early lymphomatous LNs. There is a lack of unanimity among current guidelines regarding the indications for initial staging imaging in early-stage presentation of MF in the absence of enlarged palpable LNs. OBJECTIVES To investigate how often imaging is performed in patients with early-stage presentation of MF, to assess the yield of LN imaging, and to determine what disease characteristics promoted imaging. METHODS A review of clinicopathologically confirmed newly diagnosed patients with cutaneous patch/plaque (T1/T2) MF from PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) data. RESULTS PROCLIPI enrolled 375 patients with stage T1/T2 MF: 304 with classical MF and 71 with folliculotropic MF. Imaging was performed in 169 patients (45%): 83 with computed tomography, 18 with positron emission tomography-computed tomography and 68 with ultrasound. Only nine of these (5%) had palpable enlarged (≥ 15 mm) LNs, with an over-representation of plaques, irrespectively of the 10% body surface area cutoff that distinguishes T1 from T2. Folliculotropic MF was not more frequently imaged than classical MF. Radiologically enlarged LNs (≥ 15 mm) were detected in 30 patients (18%); only seven had clinical lymphadenopathy. On multivariate analysis, plaque presentation was the sole parameter significantly associated with radiologically enlarged LNs. Imaging of only clinically enlarged LNs upstaged 4% of patients (seven of 169) to at least IIA, whereas nonselective imaging upstaged another 14% (24 of 169). LN biopsy, performed in eight of 30 patients, identified N3 (extensive lymphomatous involvement) in two and N1 (dermatopathic changes) in six. CONCLUSIONS Physical examination was a poor determinant of LN enlargement or involvement. Presence of plaques was associated with a significant increase in identification of enlarged or involved LNs in patients with early-stage presentation of MF, which may be important when deciding who to image. Imaging increases the detection rate of stage IIA MF, and identifies rare cases of extensive lymphomatous nodes, upstaging them to advanced-stage IVA2.
Collapse
Affiliation(s)
- E Hodak
- Division of Dermatology, Rabin Medical Center - Beilinson Hospital, Petach Tikva; affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - S Sherman
- Division of Dermatology, Rabin Medical Center - Beilinson Hospital, Petach Tikva; affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - E Papadavid
- Athens University Medical School, Athens, Greece
| | - M Bagot
- Hospital St Louis, Paris, France
| | - C Querfeld
- City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA
| | - P Quaglino
- Dermatologic Clinic, University of Turin Medical School, Turin, Italy
| | - H M Prince
- Sir Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia
| | - P L Ortiz-Romero
- Department of Dermatology, Hospital 12 de Octubre, Medical School, University Complutense, Madrid, Spain
| | - R Stadler
- Johannes Wesling University Medical Centre, Minden, Germany
| | - R Knobler
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| | - E Guenova
- University Hospital Zurich, Zurich, Switzerland
| | - T Estrach
- Hospital Clinico, University of Barcelona, Barcelona, Spain
| | - A Patsatsi
- Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece
| | - Y A Leshem
- Division of Dermatology, Rabin Medical Center - Beilinson Hospital, Petach Tikva; affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - H Prague-Naveh
- Division of Dermatology, Rabin Medical Center - Beilinson Hospital, Petach Tikva; affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - E Berti
- University of Milan, Milan, Italy
| | | | - R Cowan
- Christie Hospital, Manchester, UK
| | - C Jonak
- Department of Dermatology, Medical University of Vienna, Vienna, Austria
| | - V Nikolaou
- Athens University Medical School, Athens, Greece
| | - C Mitteldorf
- HELIOS Klinikum Hildesheim GmbH, University Medical Centre Göttingen, Göttingen, Germany
| | - O Akilov
- University of Pittsburgh School of Medicine, Pennsylvania, PA, USA
| | - L Geskin
- University of Columbia, New York, NY, USA
| | - R Matin
- Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | | | - L Vakeva
- Helsinki University Central Hospital, Helsinki, Finland
| | - J A Sanches
- University of São Paulo Medical School, São Paulo, SP, Brazil
| | - O Servitje
- Hospital Universatari de Bellvitge, Barcelona, Spain
| | | | - M Wobser
- University Hospital Wuerzburg, Wuerzburg, Germany
| | - J Yoo
- University Hospital Birmingham, Birmingham, UK
| | | | - A Bates
- University Hospital Southampton, Southampton, UK
| | - G Dunnill
- University Hospital Bristol, Bristol, UK
| | | | | | - U Wehkamp
- University Hospital Kiel, Kiel, Germany
| | - F Evison
- University Hospital Birmingham, Birmingham, UK
| | - E Hong
- Stanford University Medical Center, Stanford, CA, USA
| | - I Amitay-Laish
- Division of Dermatology, Rabin Medical Center - Beilinson Hospital, Petach Tikva; affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - R Stranzenbach
- Johannes Wesling University Medical Centre, Minden, Germany
| | - M Vermeer
- Leiden University Medical Centre, Leiden, the Netherlands
| | - R Willemze
- Leiden University Medical Centre, Leiden, the Netherlands
| | - W Kempf
- Kempf and PFlatz, Histologische Diagnostik, Zurich, Switzerland
| | - L Cerroni
- Department of Dermatology, Research Unit Dermatopathology, Medical University of Graz, Graz, Austria
| | | | - Y H Kim
- Stanford University Medical Center, Stanford, CA, USA
| | | |
Collapse
|
31
|
Lee SA, Kim JS, Chee HK, Hwang JJ, Ji M, Kim YH, Moon HJ, Lee WS. Clinical application of a digital thoracic drainage system for objectifying and quantifying air leak versus the traditional vacuum system: a retrospective observational study. J Thorac Dis 2021; 13:1020-1035. [PMID: 33717575 PMCID: PMC7947544 DOI: 10.21037/jtd-20-2993] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022]
Abstract
Background Digital thoracic drainage systems have recently been introduced and widely used in clinical practices in developed countries. These systems can monitor intrathoracic pressure changes and air leaks in real time, and also allow for objective and quantitative analyses, which aid in managing patients with a prolonged persistent air leak into the pleural space. We investigated the feasibility and effectiveness of such a new device versus the traditional vacuum system for treating patients with pneumothorax. Methods Closed thoracostomy drainage was carried out on 100 adult patients with primary or secondary pneumothorax between January 2017 and December 2018. All the patients were aged ≥18 years and treated with a chest tube at a single medical center by the same cardiothoracic surgeons and intensivists. Patients who underwent closed thoracostomy drainage using an indwelling 24-French chest tube were divided into 2 groups immediately before closed thoracostomy: the digital thoracic drainage group (digital group, n=50) and the traditional analogue thoracic drainage group (analogue group, n=50). The detailed information about demographic data, treatment outcome, duration of indwelling catheterization., hospital days, cost-effectiveness and patient satisfaction was evaluated. We also evaluated whether digitally recorded intrapleural pressure changes and air leaks would predict chest tube removal timing and outcome. Results The baseline parameters of the 2 groups were comparable with no significant differences in sex, age, weight or body mass index. The mean hospital day was shorter in the digital group than in the analogue group (17.96±12.23 vs. 18.32±16.64, P=0.902), and there was no statistically significant difference in the hospital length of stay between the 2 groups. Air leaks through the chest tube and duration of chest tube indwelling hours showed no significant statistical differences between the digital and analogue groups (213.47±219.80 vs. 261.94±184.47, P=0.235 and 223.44±218.75 vs 275.29±186.06, P=0.205, respectively). Total drainage amount and ambulation time per day were significantly higher in the digital group than in the analogue group [209.62±139.63 vs. 162.48±80.42 (P=0.042) and 6.42±3.62 vs.3.94±1.74 (P<0.001), respectively]. Hours of full expansion were significantly shorter and sleep disturbance caused by the noise of chest tube drainage was less in the digital group than in the analogue group [25.64±14.55 vs. 46.52±25.53 (P<0.001) and 2.38±1.03 vs. 5.70±2.87 (P<0.001), respectively]. Conclusions To date, there is no definite consensus and guidelines on the standardized digital suction system in pneumothorax. This study proposed the guidelines for the application of digital thoracic drainage systems in pneumothorax and also suggested that digital thoracic drainage systems might be a valuable tool to determine chest tube removal timing and reducing the length of hospital stay in patients with pneumothorax.
Collapse
Affiliation(s)
- Song Am Lee
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Seoul Hospital, Seoul, Republic of Korea
| | - Jun Seok Kim
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Seoul Hospital, Seoul, Republic of Korea
| | - Hyun Keun Chee
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Seoul Hospital, Seoul, Republic of Korea
| | - Jae Joon Hwang
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Seoul Hospital, Seoul, Republic of Korea
| | - Michael Ji
- Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Yo Han Kim
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Chungju Hospital, Chungju-si, Chungbuk, Republic of Korea
| | - Hyeong Ju Moon
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Chungju Hospital, Chungju-si, Chungbuk, Republic of Korea
| | - Woo Surng Lee
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Chungju Hospital, Chungju-si, Chungbuk, Republic of Korea
| |
Collapse
|
32
|
Yang J, Kim H, Shin K, Nam Y, Heo HJ, Kim GH, Hwang BY, Kim J, Woo S, Choi HS, Ko DS, Lee D, Kim YH. Molecular insights into the development of hepatic metastases in colorectal cancer: a metastasis prediction study. Eur Rev Med Pharmacol Sci 2020; 24:12701-12708. [PMID: 33378017 DOI: 10.26355/eurrev_202012_24168] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Colorectal cancer is presently the third most commonly diagnosed cancer in the United States. In this study, we identified molecular differences between hepatic and non-hepatic metastases in colorectal cancer and evaluated their prognostic significance. MATERIALS AND METHODS We downloaded primary data from the NCBI Gene Expression Omnibus (GSE6988, GSE62321, GSE50760, and GSE28722). To identify the molecular differences, we used the Significance Analysis of Microarray method. We selected nine prognostic genes (SYTL2, PTPLAD1, CDS1, RNF138, PIGR, WDR78, MYO7B, TSPAN3, and ATP5F1) with hepatic metastasis prediction score in colorectal cancer (hereafter referred to as LASSO Score). We confirmed the prognostic significance of the LASSO Score by using Kaplan-Meier survival analysis, multivariate analysis, the time-dependent area under the curve (AUC) of Uno's C-index, and the AUC of the receiver operating characteristic curve at 1-5 years. RESULTS Survival analysis revealed that a high LASSO Score is associated with a poor prognosis in colorectal cancer patients with hepatic metastases (p = 0). Analysis of C-indices and AUC values from the receiver operating characteristic curve further supported this prediction by the LASSO Score. Multivariate analysis confirmed the prognostic significance of the LASSO Score (p = 1.13e-06). CONCLUSIONS This study reveals the biological mechanisms underlying hepatic metastases in colorectal cancer and will help in developing targeted therapies for colorectal cancer.
Collapse
Affiliation(s)
- J Yang
- Department of Premedicine, School of Medicine, Pusan National University, Yangsan, South Korea.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
|
34
|
Kim BS, Kang J, Jun S, Kim H, Pak K, Kim GH, Heo HJ, Kim YH. Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET. Eur Rev Med Pharmacol Sci 2020; 24:8288-8295. [PMID: 32894535 DOI: 10.26355/eurrev_202008_22625] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE To assess associations between parameters derived from F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) and mRNA expression levels of immune checkpoint biomarkers such as programmed death receptor 1 (PD-1), programmed death-ligand 1 (PD-L1), cytotoxic T-lymphocyte antigen 4 (CTLA-4) as well as tumor mutation burden (TMB) in non-small cell lung cancer (NSCLC) patients. PATIENTS AND METHODS Integrated data were downloaded from Genomic Data Common Data Portal. Clinical, mRNA-seq, and whole exome-seq data of lung adenocarcinoma and squamous cell carcinoma from The Cancer Genome Atlas (TCGA) database were analyzed. TMB was defined as the total number of somatic missense mutations per megabase of the genome examined. Expression levels of PD-1, PD-L1, CTLA4 mRNA and TMB were collected. Correlations between imaging parameters of glucose metabolism and the expression levels of genomic biomarkers from cancers were evaluated. Bonferroni correction (adjusted p<0.0027) was applied to reduce type 1 error. RESULTS Of 31 NSCLC cases, 11 cases were adenocarcinoma (LUAD) and 20 were squamous cell carcinoma (LUSC). In linear regression analysis, texture parameters such as low gray-level run emphasis (LGRE, R2=0.48, p<0.0001), short run low gray-level emphasis (SRLGE, R2=0.45, p<0.0001) and long run low gray-level emphasis (LRLGE, R2=0.41, p=0.0001) derived from gray-level run length matrix (GLRLM) showed remarkable correlation with PD-L1 mRNA expression. Expression of PD-1, CTLA-4, and TMB failed to show any significant correlation with parameters of the F-18 FDG PET/CT. CONCLUSIONS Texture parameters derived from PET, known to indicate glucose uptake distribution, were correlated with expression of PD-L1 mRNA but not with expression of PD-1, CTLA-4 and TMB. Thus, tumoral heterogeneity could be a surrogate marker for the identification of PD-L1 level in NSCLC.
Collapse
Affiliation(s)
- B S Kim
- Department of Nuclear Medicine, Kosin University Gospel Hospital, University of Kosin College of Medicine, Busan, Republic of Korea.
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Mărginean N, Little D, Tsunoda Y, Leoni S, Janssens RVF, Fornal B, Otsuka T, Michelagnoli C, Stan L, Crespi FCL, Costache C, Lica R, Sferrazza M, Turturica A, Ayangeakaa AD, Auranen K, Barani M, Bender PC, Bottoni S, Boromiza M, Bracco A, Călinescu S, Campbell CM, Carpenter MP, Chowdhury P, Ciemała M, Cieplicka-Oryǹczak N, Cline D, Clisu C, Crawford HL, Dinescu IE, Dudouet J, Filipescu D, Florea N, Forney AM, Fracassetti S, Gade A, Gheorghe I, Hayes AB, Harca I, Henderson J, Ionescu A, Iskra ŁW, Jentschel M, Kandzia F, Kim YH, Kondev FG, Korschinek G, Köster U, Krzysiek M, Lauritsen T, Li J, Mărginean R, Maugeri EA, Mihai C, Mihai RE, Mitu A, Mutti P, Negret A, Niţă CR, Olăcel A, Oprea A, Pascu S, Petrone C, Porzio C, Rhodes D, Seweryniak D, Schumann D, Sotty C, Stolze SM, Şuvăilă R, Toma S, Ujeniuc S, Walters WB, Wu CY, Wu J, Zhu S, Ziliani S. Shape Coexistence at Zero Spin in ^{64}Ni Driven by the Monopole Tensor Interaction. Phys Rev Lett 2020; 125:102502. [PMID: 32955302 DOI: 10.1103/physrevlett.125.102502] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/24/2020] [Accepted: 07/31/2020] [Indexed: 06/11/2023]
Abstract
The low-spin structure of the semimagic ^{64}Ni nucleus has been considerably expanded: combining four experiments, several 0^{+} and 2^{+} excited states were identified below 4.5 MeV, and their properties established. The Monte Carlo shell model accounts for the results and unveils an unexpectedly complex landscape of coexisting shapes: a prolate 0^{+} excitation is located at a surprisingly high energy (3463 keV), with a collective 2^{+} state 286 keV above it, the first such observation in Ni isotopes. The evolution in excitation energy of the prolate minimum across the neutron N=40 subshell gap highlights the impact of the monopole interaction and its variation in strength with N.
Collapse
Affiliation(s)
- N Mărginean
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - D Little
- Department of Physics and Astronomy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3255, USA
- Triangle Universities Nuclear Laboratory, Duke University, Durham, North Carolina 27708-2308, USA
| | - Y Tsunoda
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - S Leoni
- Dipartimento di Fisica, Universitá degli Studi di Milano, I-20133 Milano, Italy
- INFN sezione di Milano via Celoria 16, 20133 Milano, Italy
| | - R V F Janssens
- Department of Physics and Astronomy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3255, USA
- Triangle Universities Nuclear Laboratory, Duke University, Durham, North Carolina 27708-2308, USA
| | - B Fornal
- Institute of Nuclear Physics, PAN, 31-342 Kraków, Poland
| | - T Otsuka
- Department of Physics, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- KU Leuven, Instituut voor Kern- en Stralingsfysica, 3000 Leuven, Belgium
| | - C Michelagnoli
- Institut Laue-Langevin (ILL), 71 Avenue des Martyrs, 38042 Grenoble, France
| | - L Stan
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - F C L Crespi
- Dipartimento di Fisica, Universitá degli Studi di Milano, I-20133 Milano, Italy
- INFN sezione di Milano via Celoria 16, 20133 Milano, Italy
| | - C Costache
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - R Lica
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - M Sferrazza
- Département de Physique, Université libre de Bruxelles, B-1050 Bruxelles, Belgium
| | - A Turturica
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - A D Ayangeakaa
- Department of Physics, United States Naval Academy, Annapolis, Maryland 21402, USA
| | - K Auranen
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - M Barani
- Dipartimento di Fisica, Universitá degli Studi di Milano, I-20133 Milano, Italy
- INFN sezione di Milano via Celoria 16, 20133 Milano, Italy
- Institut Laue-Langevin (ILL), 71 Avenue des Martyrs, 38042 Grenoble, France
| | - P C Bender
- Department of Physics and Applied Physics, University of Massachusetts Lowell, Lowell, Massachusetts 01854, USA
| | - S Bottoni
- Dipartimento di Fisica, Universitá degli Studi di Milano, I-20133 Milano, Italy
- INFN sezione di Milano via Celoria 16, 20133 Milano, Italy
| | - M Boromiza
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - A Bracco
- Dipartimento di Fisica, Universitá degli Studi di Milano, I-20133 Milano, Italy
- INFN sezione di Milano via Celoria 16, 20133 Milano, Italy
| | - S Călinescu
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - C M Campbell
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M P Carpenter
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - P Chowdhury
- Department of Physics and Applied Physics, University of Massachusetts Lowell, Lowell, Massachusetts 01854, USA
| | - M Ciemała
- Institute of Nuclear Physics, PAN, 31-342 Kraków, Poland
| | | | - D Cline
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - C Clisu
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - H L Crawford
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - I E Dinescu
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - J Dudouet
- Université Lyon 1, CNRS/IN2P3, IPN-Lyon, F-69622, Villeurbanne, France
| | - D Filipescu
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - N Florea
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - A M Forney
- Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, USA
| | - S Fracassetti
- Dipartimento di Fisica, Universitá degli Studi di Milano, I-20133 Milano, Italy
- INFN sezione di Milano via Celoria 16, 20133 Milano, Italy
| | - A Gade
- Department of Physics and Astronomy, Michigan State University, East Lansing, Michigan 48824, USA
- National Superconducting Cyclotron Laboratory, Michigan State University, East Lansing, Michigan 48824, USA
| | - I Gheorghe
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - A B Hayes
- National Nuclear Data Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - I Harca
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - J Henderson
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - A Ionescu
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - Ł W Iskra
- INFN sezione di Milano via Celoria 16, 20133 Milano, Italy
| | - M Jentschel
- Institut Laue-Langevin (ILL), 71 Avenue des Martyrs, 38042 Grenoble, France
| | - F Kandzia
- Institut Laue-Langevin (ILL), 71 Avenue des Martyrs, 38042 Grenoble, France
| | - Y H Kim
- Institut Laue-Langevin (ILL), 71 Avenue des Martyrs, 38042 Grenoble, France
| | - F G Kondev
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - G Korschinek
- Technische Universität München, 80333 München, Germany
| | - U Köster
- Institut Laue-Langevin (ILL), 71 Avenue des Martyrs, 38042 Grenoble, France
| | - M Krzysiek
- Institute of Nuclear Physics, PAN, 31-342 Kraków, Poland
| | - T Lauritsen
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - J Li
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - R Mărginean
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - E A Maugeri
- Paul Scherrer Institut, 5232 Villigen, Switzerland
| | - C Mihai
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - R E Mihai
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - A Mitu
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - P Mutti
- Institut Laue-Langevin (ILL), 71 Avenue des Martyrs, 38042 Grenoble, France
| | - A Negret
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - C R Niţă
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - A Olăcel
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - A Oprea
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - S Pascu
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - C Petrone
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - C Porzio
- Dipartimento di Fisica, Universitá degli Studi di Milano, I-20133 Milano, Italy
- INFN sezione di Milano via Celoria 16, 20133 Milano, Italy
| | - D Rhodes
- Department of Physics and Astronomy, Michigan State University, East Lansing, Michigan 48824, USA
- National Superconducting Cyclotron Laboratory, Michigan State University, East Lansing, Michigan 48824, USA
| | - D Seweryniak
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - D Schumann
- Paul Scherrer Institut, 5232 Villigen, Switzerland
| | - C Sotty
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - S M Stolze
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - R Şuvăilă
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - S Toma
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - S Ujeniuc
- Horia Hulubei National Institute of Physics and Nuclear Engineering-IFIN HH, Bucharest 077125, Romania
| | - W B Walters
- Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, USA
| | - C Y Wu
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - J Wu
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Zhu
- National Nuclear Data Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - S Ziliani
- Dipartimento di Fisica, Universitá degli Studi di Milano, I-20133 Milano, Italy
- INFN sezione di Milano via Celoria 16, 20133 Milano, Italy
| |
Collapse
|
36
|
Asumda FZ, Hassan MA, Kim YH, Campbell NA, Luo X, O'Brien DR, Buhrow SA, Reid JM, Moore MJ, Ben-Yair VK, Fathi R, Levitt ML, Lucien-Matteoni F, Leiting JL, Truty MJ, Roberts LR. Abstract 3078: Effects of upamostat and opaganib on cholangiocarcinoma patient derived xenografts. Cancer Res 2020. [DOI: 10.1158/1538-7445.am2020-3078] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Upamostat is an orally available small molecule serine protease inhibitor that is a highly potent inhibitor of trypsin 1, trypsin 2 and trypsin 3 (PRSS1/2/3) as well as urokinase-type plasminogen activator (uPA) which are expressed in many cancers and mediate cell migration, invasion and tissue remodeling. Opaganib (ABC294640), a novel, orally available small molecule is a specific inhibitor of sphingosine kinase 2 (SPHK2), which phosphorylates sphingosine to sphingosine-1-phosphate (S-1-P). While proliferation induced by S-1-P is regulated by both sphingosine kinase 1 (SPHK1) and SPHK2, SPHK2 appears to be more involved in cancer. We aimed to investigate the potential antitumor effect of upamostat and opaganib, individually and in combination, on cholangiocarcinoma (CCA) patient derived xenografts (PDX) in nude mice.
Methods: PAX165, a PDX from a surgically resected CCA, expresses substantial levels of SPHK2, PRSS1, PRSS2 and PRSS3. 4 groups of 18 mice were treated with either drug or both. Mouse weights and tumor volumes were measured. In addition, experiments were conducted using the chorioallantoic membrane (CAM) of chicken embryos.
Results: Table 1 shows the average tumor size for the control, upamostat, opaganib, and upamostat+opaganib groups at the study end point (Day 42). Tumor volumes in the upamostat, opaganib, and upamostat+opagnib groups were significantly decreased compared to the control group. The CAM experiments are ongoing and will be presented at the AACR Annual Meeting.
Change in tumor volumes (mean) of CCA PDX after opaganib, upamostat or combination treatmentControlOpaganibUpamostatOpaganib+UpamostatPre-treatment129.9128.7118.8126.8Day 42198.6102.093.3186.09Percent change Day 0-42+53%-21%-21%-32%P value vs. control0.00020.00100.0008
Conclusion: This preclinical study demonstrated that upamostat and opaganib resulted in tumor regression in mice. Body weights of the mice showed no significant inter- or intra- group differences. The combination of upamostat and opaganib treatment showed greater regression compared to either upamostat or opaganib alone. Studies are underway to identify the molecular mechanisms of their interaction.
Citation Format: Faizal Z. Asumda, Mohamed A. Hassan, Yo Han Kim, Nellie A. Campbell, Xin Luo, Daniel R. O'Brien, Sarah A. Buhrow, Joel M. Reid, Michael J. Moore, Vered Katz Ben-Yair, Reza Fathi, Mark L. Levitt, Fabrice Lucien-Matteoni, Jennifer L. Leiting, Mark J. Truty, Lewis R. Roberts. Effects of upamostat and opaganib on cholangiocarcinoma patient derived xenografts [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 3078.
Collapse
Affiliation(s)
| | | | - Yo Han Kim
- 1Mayo Clinic College of Medicine and Science, Rochester, MN
| | | | - Xin Luo
- 1Mayo Clinic College of Medicine and Science, Rochester, MN
| | | | | | - Joel M. Reid
- 1Mayo Clinic College of Medicine and Science, Rochester, MN
| | | | | | | | | | | | | | - Mark J. Truty
- 1Mayo Clinic College of Medicine and Science, Rochester, MN
| | | |
Collapse
|
37
|
Han S, Kim YH, Choi HY, Soh DJ, Kim J, Nam J, Kim JW, Bae KS, Lim HS. First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP-ribose) Polymerase-1 Inhibitor, JPI-289, in Healthy Volunteers. Drug Des Devel Ther 2020; 14:3189-3199. [PMID: 32801651 PMCID: PMC7415440 DOI: 10.2147/dddt.s235802] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2019] [Accepted: 06/26/2020] [Indexed: 11/23/2022] Open
Abstract
Background Poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor has therapeutic potential for acute ischemic stroke by suppressing microglial activation and facilitating neuroprotection. In this first-in-human study, we investigate the safety, tolerability and pharmacokinetics (PK) of JPI-289 in healthy male volunteers. Subjects and Methods In single ascending dose (SAD) study, 35, 75, 150, 300, 600 mg JPI-289 or placebo was infused intravenously over 30 minutes to 40 subjects. In multiple ascending dose (MAD) study, 150, 300, 450 mg JPI-289 or placebo was infused over 1 hour every 12 hours to each of 24 subjects for 3.5 days (7 times). The plasma and urine concentrations of JPI-289 and its metabolites were determined. Results In the SAD study, AUClast and Cmax tended to increase supra-proportionally especially at higher doses in SAD study. However, Cmax showed dose-proportionality in the range of 75–600mg. JPI-289 reached a mean Tmax within 0.50 hour after dosing and a mean elimination half-life (t1/2) was 2.18 to 3.21 hours. In the MAD study, observed accumulation index ranged from 1.52 to 1.76. The effective half-life of JPI-289 was 1.88 to 3.05 hours, indicating that the plasma JPI-289 concentration rapidly reaches steady state. % recovered of JPI-289 measured in urine was 1.59–9.05%. In both studies, concentration of metabolites was less than 10% of JPI-289. Adverse events reported in the study were all mild in intensity and resolved without any sequelae. Conclusion The tolerable dose ranges and pharmacokinetic characteristics of JPI-289 evaluated in these studies will be useful in further clinical development of JPI-289.
Collapse
Affiliation(s)
- Sungpil Han
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Yo Han Kim
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Hee Youn Choi
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Dong-Jun Soh
- Clinical Development Team, Jeil Pharmaceutical Co. Ltd, Seoul, Republic of Korea
| | - Jeongmin Kim
- Clinical Development Team, Jeil Pharmaceutical Co. Ltd, Seoul, Republic of Korea
| | - Joonwoo Nam
- Clinical Development Team, Jeil Pharmaceutical Co. Ltd, Seoul, Republic of Korea
| | - Jong-Woo Kim
- Clinical Development Team, Jeil Pharmaceutical Co. Ltd, Seoul, Republic of Korea
| | - Kyun-Seop Bae
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - Hyeong-Seok Lim
- Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
38
|
Ha M, Son YR, Kim J, Park SM, Hong CM, Choi D, Kang W, Kim JH, Lee KJ, Park D, Han ME, Oh SO, Lee D, Kim YH. TEK is a novel prognostic marker for clear cell renal cell carcinoma. Eur Rev Med Pharmacol Sci 2020; 23:1451-1458. [PMID: 30840266 DOI: 10.26355/eurrev_201902_17102] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. However, effective therapeutics for ccRCC are lacking. Novel biomarkers could provide critical information when determining prognoses for patients with ccRCC. In this study, we sought to determine if the expression of receptor tyrosine kinase (TEK) could be a potential novel prognostic biomarker for ccRCC. TEK, originally identified as an endothelial cell-specific receptor, plays an important role in the modulation of vasculogenesis and remodeling. Altered TEK expression has been observed in tumor tissues (e.g., oral squamous cell carcinomas, leukemia) and breast, gastric and thyroid cancers. However, the role of TEK in ccRCC remains unknown. PATIENTS AND METHODS Differential TEK expression between non-metastatic (stage M0) and metastatic (stage M1) ccRCC patient cohorts was determined from The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC). Furthermore, TEK expression was assessed as a prognostic factor using the time-dependent area under the curve (AUC) of Uno's C-index, the AUC value of the receiver operating characteristics (ROC) at 5 years, Kaplan-Meier survival curves and multivariate analyses. RESULTS A Kaplan-Meier curve analysis revealed that the downregulation of TEK expression was associated with a poor prognosis for patients with ccRCC with good discrimination (p<0.0001 and p=0.0044 for the TGCA and ICGC cohorts, respectively). Analyses of C-indices and receiver operating characteristic AUC values further support this discriminative ability. Moreover, multivariate analyses showed the prognostic significance of TEK expression levels (p<0.001). CONCLUSIONS Although additional clinical investigations will be needed, our results suggest that TEK is a potential biomarker for ccRCC.
Collapse
Affiliation(s)
- M Ha
- Department of Anatomy, Pusan National University School of Medicine, Yangsan, Republic of Korea.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Choi SJ, Kwak DW, Kil K, Kim SC, Kwon JY, Kim YH, Na S, Bae JG, Cha HH, Shim JY, Oh KY, Lee KA, Kim SM, Cho IA, Lee SM, Cho GJ, Jo YS, Choi GY, Choi SK, Hur SE, Hwang HS, Kim YJ. Vaginal compared with intramuscular progestogen for preventing preterm birth in high-risk pregnant women (VICTORIA study): a multicentre, open-label randomised trial and meta-analysis. BJOG 2020; 127:1646-1654. [PMID: 32536019 DOI: 10.1111/1471-0528.16365] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/02/2020] [Indexed: 11/29/2022]
Abstract
OBJECTIVE To compare the efficacy of two types of progestogen therapy for preventing preterm birth (PTB) and to review the relevant literature. DESIGN A multicentre, randomised, open-label, equivalence trial and a meta-analysis. SETTING Tertiary referral hospitals in South Korea. POPULATION Pregnant women with a history of spontaneous PTB or short cervical length (<25 mm). METHODS Eligible women were screened and randomised at 16-22 weeks of gestation to receive either 200 mg of vaginal micronised progesterone daily (vaginal group) or an intramuscular injection of 250 mg 17α-hydroxyprogesterone caproate weekly (IM group). Stratified randomisation was carried out according to participating centres and indications for progestogen therapy. This trial was registered at ClinicalTrials.gov (NCT02304237). MAIN OUTCOME MEASURE Preterm birth (PTB) before 37 weeks of gestation. RESULTS A total of 266 women were randomly assigned and a total of 247 women (119 and 128 women in the vaginal and IM groups, respectively) were available for the intention-to-treat analysis. Risks of PTB before 37 weeks of gestation did not significantly differ between the two groups (22.7 versus 25.8%, P = 0.571). The difference in PTB risk between the two groups was 3.1% (95% CI -7.6 to 13.8%), which was within the equivalence margin of 15%. The meta-analysis results showed no significant differences in the risk of PTB between the vaginal and IM progestogen treatments. CONCLUSION Compared with vaginal progesterone, treatment with intramuscular progestin might increase the risk of PTB before 37 weeks of gestation by as much as 13.8%, or reduce the risk by as much as 7.6%, in women with a history of spontaneous PTB or with short cervical length. TWEETABLE ABSTRACT Vaginal and intramuscular progestogen showed equivalent efficacy for preventing preterm birth before 37 weeks of gestation.
Collapse
Affiliation(s)
- S-J Choi
- Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - D W Kwak
- Ajou University School of Medicine, Suwon, Korea
| | - K Kil
- Yeouido St Mary's Hospital, The Catholic University of Korea, Seoul, Korea
| | - S-C Kim
- Pusan National University College of Medicine, Pusan, Korea
| | - J-Y Kwon
- Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Y H Kim
- Chonnam National University Medical School, Gwangju, Korea
| | - S Na
- Kangwon National University Hospital, School of Medicine Kangwon National University, Chuncheon, Korea
| | - J-G Bae
- Keimyung University School of Medicine, Daegu, Korea
| | - H-H Cha
- Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea
| | - J-Y Shim
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - K Y Oh
- School of Medicine, Eulji University, Daejeon, Korea
| | - K A Lee
- Kyung Hee University School of Medicine, Seoul, Korea
| | - S M Kim
- Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea
| | - I A Cho
- Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea
| | - S M Lee
- Seoul National University College of Medicine, Seoul, Korea
| | - G J Cho
- Korea University College of Medicine, Seoul, Korea
| | - Y S Jo
- St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea
| | - G Y Choi
- Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University, Seoul, Korea
| | - S K Choi
- College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - S E Hur
- Konyang University Hospital, Daejeon, Korea
| | - H S Hwang
- Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea
| | - Y J Kim
- College of Medicine, Ewha Womans University, Seoul, Korea
| | | |
Collapse
|
40
|
Singh JP, Park JY, Singh V, Kim SH, Lim WC, Kumar H, Kim YH, Lee S, Chae KH. Correlating the size and cation inversion factor in context of magnetic and optical behavior of CoFe 2O 4 nanoparticles. RSC Adv 2020; 10:21259-21269. [PMID: 35518780 PMCID: PMC9054365 DOI: 10.1039/d0ra01653e] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2020] [Accepted: 05/26/2020] [Indexed: 12/20/2022] Open
Abstract
Herein, the size dependent behavior of cobalt ferrite nanoparticles was investigated using synchrotron radiation based techniques. Scanning electron micrographs revealed the enhancement of particle/crystallite size with increase of annealing temperature. Moreover, the shape of these particles also changed with increase of crystallite size. Saturation magnetization increased with increase of crystallite size. The higher saturation magnetization for larger crystallite size nanoparticles was attributed to a cation distribution similar to that of bulk CoFe2O4. The optical band-gap of these nanoparticles decreased from 1.9 eV to 1.7 eV with increase of crystallite size. The enhancement of the optical band-gap for smaller crystallites was due to phenomena of optical confinement occurring in the nanoparticles. Fe L Co L-edge near edge extended X-ray absorption fine structure (NEXAFS) measurements showed that Fe and Co ions remain in the 3+ and 2+ state in these nanoparticles. The results obtained from Fe & Co K-edge X-ray absorption near edge structure (XANES)-imaging experiments further revealed that this oxidation state was possessed by even the crystallites. Extended X-ray absorption fine structure (EXAFS) measurements revealed distribution of Fe and Co ions among tetrahedral (A) and octahedral (B) sites of the spinel structure which corroborates the results obtained from Rietveld refinement of X-ray diffraction patterns (XRD). X-ray magnetic circular di-chroism (XMCD) measurements revealed negative exchange interaction among the ions situated in tetrahedral (A) and octahedral (B) sites. Theoretical and experimental calculated magnetic moments revealed the dominancy of size effects rather than the cation redistribution in the spinel lattice of CoFe2O4 nanoparticles.
Collapse
Affiliation(s)
- Jitendra Pal Singh
- Pohang Accelerator Lab, Pohang University of Science and Technology Pohang 37673 Republic of Korea
| | - Jae Yeon Park
- Radiation Equipment Research Division, Korea Atomic Energy Research Institute Jeongup 56212 Republic of Korea
| | - Varsha Singh
- Advanced Analysis Center, Korea Institute of Science and Technology Seoul 02792 Republic of Korea
| | - So Hee Kim
- Advanced Analysis Center, Korea Institute of Science and Technology Seoul 02792 Republic of Korea
| | - Weon Cheol Lim
- Advanced Analysis Center, Korea Institute of Science and Technology Seoul 02792 Republic of Korea
| | - Hemaunt Kumar
- Department of Applied Sciences, Rajkiya Engineering College Bijnor-246725 India
| | - Y H Kim
- Pohang Accelerator Lab, Pohang University of Science and Technology Pohang 37673 Republic of Korea
| | - Sangsul Lee
- Pohang Accelerator Lab, Pohang University of Science and Technology Pohang 37673 Republic of Korea
- Xavisoptics Ltd. Pohang 37673 Republic of Korea
| | - Keun Hwa Chae
- Advanced Analysis Center, Korea Institute of Science and Technology Seoul 02792 Republic of Korea
| |
Collapse
|
41
|
Song SK, Jang HU, Kim YH, Lee BH, Lee MM. Overexpression of three related root-cap outermost-cell-specific C2H2-type zinc-finger protein genes suppresses the growth of Arabidopsis in an EAR-motif-dependent manner. BMB Rep 2020. [PMID: 32172729 PMCID: PMC7118352 DOI: 10.5483/bmbrep.2020.53.3.286] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
The root meristem of Arabidopsis thaliana is protected by the root cap, the size of which is tightly regulated by the balance between the formative cell divisions and the dispersal of the outermost cells. We isolated an enhancer-tagged dominant mutant displaying the short and twisted root by the overexpression of ZINC-FINGER OF ARABIDOPSIS THALIANA1 (ZAT1) encoding an EAR motif-containing zinc-finger protein. The growth inhibition by ZAT1 was shared by ZAT4 and ZAT9, the ZAT1 homologues. The ZAT1 promoter was specifically active in the outermost cells of the root cap, in which ZAT1-GFP was localized when expressed by the ZAT1 promoter. The outermost cell-specific expression pattern of ZAT1 was not altered in the sombrero (smb) or smb bearskin1 (brn1) brn2 accumulating additional root-cap layers. In contrast, ZAT4-GFP and ZAT9- GFP fusion proteins were distributed to the inner root-cap cells in addition to the outermost cells where ZAT4 and ZAT9 promoters were active. Overexpression of ZAT1 induced the ectopic expression of PUTATIVE ASPARTIC PROTEASE3 involved in the programmed cell death. The EAR motif was essential for the growth inhibition by ZAT1. These results suggest that the three related ZATs might regulate the maturation of the outermost cells of the root cap.
Collapse
Affiliation(s)
- Sang-Kee Song
- Department of Biology, Chosun University, Gwangju 61452, Korea
| | - Hyeon-Ung Jang
- Department of Biology, Chosun University, Gwangju 61452, Korea
| | - Yo Han Kim
- Department of Biology, Chosun University, Gwangju 61452, Korea
| | - Bang Heon Lee
- Department of Biology, Chosun University, Gwangju 61452, Korea
| | - Myeong Min Lee
- Department of Systems Biology, Yonsei University, Seoul 03722, Korea
| |
Collapse
|
42
|
Tetsuno K, Ajimura S, Akutagawa K, Batpurev T, Chan WM, Fushimi K, Hazama R, Iida T, Ikeyama Y, Khai BT, Kishimoto T, Lee KK, Li X, Matsuoka K, Matsuoka K, Mizukoshi K, Mori Y, Nakajima K, Noithong P, Nomachi M, Ogawa I, Ohsumi H, Ozawa K, Shimizu K, Shokati M, Soberi F, Suzuki K, Takemoto Y, Takihira Y, Tamagawa Y, Tozawa M, Trang VTT, Umehara S, Yamamoto K, Yoshida S, Kim I, Kwon DH, Kim HL, Lee HJ, Lee MK, Kim YH. Status of 48Ca double beta decay search and its future prospect in CANDLES. ACTA ACUST UNITED AC 2020. [DOI: 10.1088/1742-6596/1468/1/012132] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
43
|
Lee SH, Park JS, Kim SY, Kim DS, Kim YW, Chung MP, Uh ST, Park CS, Park SW, Jeong SH, Park YB, Lee HL, Shin JW, Lee JH, Jegal Y, Lee HK, Kim YH, Song JW, Park MS. Clinical features and prognosis of patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 2020; 23:678-684. [PMID: 31315699 DOI: 10.5588/ijtld.18.0194] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
<sec> <title>BACKGROUND</title> Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) share common risk factors. They could therefore be expressed in a single patient. However, the prevalence, clinical characteristics and prognosis of individuals with comorbid IPF and COPD are not known. </sec> <sec> <title>METHOD</title> From 2003 to 2007, the Korean Interstitial Lung Disease Study Group created a register for idiopathic interstitial pneumonia using 2002 ATS/ERS (American Thoracic Society/European Respiratory Society) criteria. Of the 1546 IPF patients assessed, 143 had decreased lung function consistent with COPD (IPF-COPD). COPD was diagnosed based on age (≥40 years) and pulmonary function (forced expiratory volume in 1 sec [FEV1]/forced vital capacity [FVC] ratio < 0.7). </sec> <sec> <title>RESULTS</title> The median age of the IPF-COPD group was 71.0 years (interquartile range 66.0-76.0); most patients were male (88.1%). FVC (%) was significantly higher in the IPF-COPD group; however, FEV1 (%) was significantly lower in the IPF-COPD group (P < 0.001). Diffusing capacity of the lung for carbon monoxide (DLCO) was not significantly different between the two groups. In survival analysis, age and FVC (%), but not COPD, were significantly associated with prognosis (respectively P = 0.003, 0.001 and 0.401). COPD severity was also not related to prognosis (P = 0.935). </sec> <sec> <title>CONCLUSION</title> The prevalence of IPF-COPD was estimated to be ∼9.2% among all IPF patients; prognosis of patients with IPF-COPD was not worse than those with IPF alone. </sec>.
Collapse
Affiliation(s)
- S H Lee
- Yonsei University College of Medicine, Seoul, Department of Internal Medicine, National University College of Medicine, Division of Pulmonary and Critical Care Medicine, Seoul National University Bundang Hospital, Seoul
| | - J S Park
- Department of Internal Medicine, National University College of Medicine, Division of Pulmonary and Critical Care Medicine, Seoul National University Bundang Hospital, Seoul
| | - S Y Kim
- Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Institute of Chest Diseases, Yonsei University College of Medicine, Seoul
| | - D S Kim
- Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul
| | - Y W Kim
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul National University College of Medicine, Seoul
| | - M P Chung
- Division of Pulmonary and Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul
| | - S T Uh
- Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul
| | - C S Park
- Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Gyeonggi-do
| | - S W Park
- Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Gyeonggi-do
| | - S H Jeong
- Division of Pulmonology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon
| | - Y B Park
- Division of Pulmonary, Allergy & Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul
| | - H L Lee
- Pulmonary Division, Department of Internal Medicine, Inha University Hospital, Incheon
| | - J W Shin
- Division of Pulmonary Medicine, Department of Internal Medicine, Chung Ang University College of Medicine, Seoul
| | - J H Lee
- Department of Internal Medicine, Ewha Womans University School of Medicine, Ewha Medical Research Institute, Seoul
| | - Y Jegal
- Division of Pulmonary Medicine, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan
| | - H K Lee
- Division of Critical Care and Pulmonary Medicine, Department of Internal Medicine, Inje University Pusan Paik Hospital, Busan
| | - Y H Kim
- Division of Allergy and Pulmonology, Department of Internal Medicine, Bucheon St Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, South Korea
| | - J W Song
- Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul
| | - M S Park
- Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Institute of Chest Diseases, Yonsei University College of Medicine, Seoul
| |
Collapse
|
44
|
Meaney KD, Kim YH, Geppert-Kleinrath H, Herrmann HW, Hopkins LB, Hoffman NM. Diagnostic signature of the compressibility of the inertial-confinement-fusion pusher. Phys Rev E 2020; 101:023208. [PMID: 32168628 DOI: 10.1103/physreve.101.023208] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2019] [Accepted: 02/06/2020] [Indexed: 11/07/2022]
Abstract
Carbon shell areal density measurements from many types of inertial confinement fusion implosions at the National Ignition Facility (NIF) demonstrate that the final state of the outside portion of the shell is set primarily by capsule coast time, the coasting period between main laser shut off and peak fusion output. However, the fuel areal density does not correlate with the increasing carbon compression. While two-dimensional (2D) radiation-hydrodynamic simulations successfully capture the carbon compression, energy must be added to the simulated fuel-ice layer to reproduce fuel areal density measurements. The data presented demonstrates that the degradation mechanisms that reduce the compressibility of the fuel do not reduce the compressibility of the ablator.
Collapse
Affiliation(s)
- K D Meaney
- Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA
| | - Y H Kim
- Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA
| | | | - H W Herrmann
- Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA
| | - L Berzak Hopkins
- Lawerence Livermore National Laboratory, Livermore, California, 94550, USA
| | - N M Hoffman
- Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA
| |
Collapse
|
45
|
Kim JS, Lee SA, Chee HK, Hwang JJ, Kim HY, Kim JY, Choi SM, Kim YH, Lee WS. Femoral arteriovenous fistula associated with surgery of proximal femoral fracture: a systematic review of the literature and case presentation. Ann Transl Med 2020; 8:291. [PMID: 32355735 PMCID: PMC7186609 DOI: 10.21037/atm.2020.03.08] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Background Proximal femoral fracture (PFF), such as intertrochanteric femoral fracture or femur neck fracture, and its management are crucial issues to surgeons. PFF has been dramatically is becoming exponentially prevalent, and it is at high risk of complication and mortality because it is frequently associated with serious trauma and advanced age, especially in patients treated with anticoagulants or antiplatelet agents. Surgical management is essential for the treatment of PFF. Unfortunately, current surgical procedures have been related to accompanied by vascular complications, including laceration, hemorrhage, thrombosis, embolism, intimal flap tear and pseudoaneurysm. Furthermore, these vascular injuries following surgical management of PFF are potentially limb- and life-threatening. Of the complications after operation of PFF, femoral arteriovenous fistula (AVF) is rare, but remains a challenging problem because it is frequently associated with significantly high mortality and morbidity and is very difficult to treat. Methods A systematic literature review was conducted using the PRISMA guidelines with no language restriction. We searched scientific publications via PubMed, Embase, Cochrane central register of controlled trial, Google Scholar, the KoreaMed and the Research Information Sharing Service database. The goal of this study was to report on the incidence, clinical presentation, diagnosis, treatment, associated complications, morbidity and mortality of femoral AVF caused by PFF and to draw special attention to its prevention and management. Results A total of 7 case reports on femoral AVF associated with operation of PFF were identified, and one our case was added to the systematic analysis. Of the 8 cases, 4 were male and 4 were female under the age of 67.87±18.44; 6 (75.0%) survived without any events, 1 (12.5%) survived with a sequela of peroneal nerve impairment, and 1 (12.5%) died of multi-organ failure and hypovolemia. Conclusions The incidence of femoral AVF associated with PFF is extremely low, though it appears to increase with the rising frequency of PFF. With a very few exceptions, complications following internal fixation are potentially limb- and life-threatening. There is still no definite consensus on the standardized diagnostic or therapeutic modalities. Therefore, surgeons should keep in mind that this serious complication requires early diagnosis and prompt treatment, which should not be underestimated. Femoral AVF following operation of PFF should be meticulously managed, because untreated fistulae result in serious unexpected complications including renin-mediated hypertension, high-output heart failure and venous and/or arterial insufficiency. Surgical treatment is still the gold standard for such cases, but in limited cases endovascular procedures using embolization and closure device can be a good treatment option.
Collapse
Affiliation(s)
- Jun Seok Kim
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Seoul Hospital, Seoul, Republic of Korea
| | - Song Am Lee
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Seoul Hospital, Seoul, Republic of Korea
| | - Hyun Keun Chee
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Seoul Hospital, Seoul, Republic of Korea
| | - Jae Joon Hwang
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Seoul Hospital, Seoul, Republic of Korea
| | - Hye Young Kim
- Department of Anesthesia and Pain Medicine, School of Medicine, Konkuk University, Konkuk University Chungju Hospital, Chungju-si, Chungbuk, Republic of Korea
| | - Jin Yong Kim
- Department of Emergency Medicine, School of Medicine, Konkuk University, Konkuk University Chungju Hospital, Chungju-si, Chungbuk, Republic of Korea
| | - Seung Myung Choi
- Department of Orthopedic Surgery, School of Medicine, Konkuk University, Konkuk University Chungju Hospital, Chungju-si, Chungbuk, Republic of Korea
| | - Yo Han Kim
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Chungju Hospital, Chungju-si, Chungbuk, Republic of Korea
| | - Woo Surng Lee
- Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Chungju Hospital, Chungju-si, Chungbuk, Republic of Korea
| |
Collapse
|
46
|
Seo M, Won CW, Kim S, Yoo JH, Kim YH, Kim BS. The Association of Gait Speed and Frontal Lobe among Various Cognitive Domains: The Korean Frailty and Aging Cohort Study (KFACS). J Nutr Health Aging 2020; 24:91-97. [PMID: 31886814 DOI: 10.1007/s12603-019-1276-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
OBJECTIVE The aim of this study was to determine how gait speed and frontal lobe functionsin community-dwelling older adults in Korea. DESIGN This was a cross-sectional study. SETTING The study used data from the Korean Frailty and Aging Cohort Survey (KFACS), a multi-center longitudinal study addressing 10 centers across urban, rural, and suburban communities in Korea, between 2016 and 2017. PARTICIPANTS A total of 1552 older adults who underwent both gait speed tests and cognitive functions tests during the investigation of the KFACS. MEASUREMENTS Gait speed was assessed by asking participants to walk from a starting point to a point 4 meters away at a normal gait. Cognitive functions were evaluated using various standardized cognitive functions tests. RESULTS Gait speed was slower when participants were older or less educated The percentage of women, higher BMI, people with lower incomes, singles, smokers, and drinkers was high in the slower gait group. Also, all cognitive function scores were low and depression score was high in the group with slower walking speed. The slower walking speed showed low physical activity score and high prevalence of hypertension, osteoarthritis and osteoporosis. Among the seven cognitive functions (MMSE, memory, TMT, Recall, Recognition, digit span, and Fab), only TMT showed no significant difference between different gait speed groups. The other six cognitive functions showed higher results in the fastest gait speed group (T3), Participants in middle gait speed group (T2) also showed higher results in five of the seven cognitive function scores as well (Memory, Recall, Recognition, digit span, and Fab). CONCLUSION In this study, we found correlation between the slower gait speeds and the decrease in cognitive function, and especially the frontal lobe dysfunction was most prominent of all cognitive dysfunctions.
Collapse
Affiliation(s)
- M Seo
- B.S. Kim, Kyunghee hospital, Republic of Korea,+82-10-8232-8696, FAX: +82-2-958-8699,
| | | | | | | | | | | |
Collapse
|
47
|
Kim JE, Kim YH, Park AY, Lee HJ, Lee JH. Experimental Investigation on the Tissue Response Induced by Face-Lifting Mesh Suspension Thread in Rats. Ann Dermatol 2019; 31:645-653. [PMID: 33911664 PMCID: PMC7992597 DOI: 10.5021/ad.2019.31.6.645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2019] [Revised: 08/22/2019] [Accepted: 09/18/2019] [Indexed: 11/23/2022] Open
Abstract
Background Face-lifting procedures are often performed to hide the effects of aging. Thread-lifting, a minimally invasive technique for the correction of facial aging, has become increasingly popular, and various materials for the procedure have been developed. Objective This study compared tissue responses to two types of threading sutures placed under rat skin: polypropylene (PP) monofilament mesh suspension thread (a novel face-lifting material) and polydioxanone (PDO) barbed thread. Methods Eight rats each were assigned to the PP monofilament mesh suspension, PDO barbed thread, and control groups. Tissue reactions were evaluated 28 days after subcutaneous loading of the materials. Results Significant increases in tensile strength and the mean area occupied by collagen fibers were evident in skin loaded with PDO barbed thread and PP monofilament mesh suspension thread compared to control skin (p<0.05). Compared to sites loaded with PDO barbed thread, those loaded with PP monofilament mesh suspension thread showed a significant increase in the number of collagen fibers and a lower grade of inflammation (p<0.05). Conclusion PP monofilament mesh suspension thread has skin-rejuvenating effects comparable to those of PDO barbed thread, but induces a less severe inflammatory response. This indicates that it is a safe and effective material for use in thread-lifting procedures on aging skin.
Collapse
Affiliation(s)
- Jung Eun Kim
- Department of Dermatology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
| | - Yo Han Kim
- Department of Plastic Surgery, Artinu Plastic Surgery Clinic, Hwaseong, Korea
| | - A Young Park
- Department of Dermatology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
| | - Ho Jung Lee
- Department of Dermatology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
| | - Jong Hun Lee
- Department of Plastic and Reconstructive Surgery, Eulji General Hospital, Eulji University School of Medicine, Seoul, Korea
| |
Collapse
|
48
|
Zylstra AB, Herrmann HW, Kim YH, McEvoy A, Meaney K, Glebov VY, Forrest C, Rubery M. Improved calibration of the OMEGA gas Cherenkov detector. Rev Sci Instrum 2019; 90:123504. [PMID: 31893806 DOI: 10.1063/1.5128765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/22/2019] [Accepted: 11/24/2019] [Indexed: 06/10/2023]
Abstract
Inertial fusion implosions are diagnosed using γ rays to characterize the implosion physics or measure basic nuclear properties, including cross sections. For the latter, previously reported measurements at laser facilities using gas Cherenkov detectors are limited by a large systematic uncertainty in the detector response. We present a novel in situ calibration technique using neutron inelastic scattering, which we apply to the new GCD-3 detector. The calibration accuracy is improved by ∼3× over the previous method.
Collapse
Affiliation(s)
- A B Zylstra
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - H W Herrmann
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - Y H Kim
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - A McEvoy
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - K Meaney
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - V Yu Glebov
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623, USA
| | - C Forrest
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623, USA
| | - M Rubery
- Plasma Physics Department, AWE plc, Reading RG7 4PR, United Kingdom
| |
Collapse
|
49
|
Abstract
OBJECTIVES The International Council of Nurses supports the development of International Classification for Nursing Practice® (ICNP®) catalogues to support the construction of electronic health records and evidence-based practice. Such a catalogue is needed for inpatient falls. METHODS The ICNP®-Based Inpatient Fall-Prevention Catalogue ('The Catalogue') was developed following the six steps recommended by the International Council of Nurses: (1) identifying inpatient falls as a priority, (2) gathering relevant concepts from 10 international guidelines and comparing locally defined sets of fall-prevention terms, (3) mapping the concepts to the ICNP® terminology, (4) identifying new concepts, (5) conducting a clinical face validation with a 12-member panel and finalizing The Catalogue and (6) setting a strategy for dissemination. The high-level structure of the International Classification for Patient Safety was used as a theoretical framework. RESULTS Eighteen nursing care elements and 141 terms were identified. A local vocabulary set had 89 terms (63.1%) that all corresponded to the identified terms. The exact and post-coordination mapping rates to the ICNP® were 75% and 40.6% for assessment/diagnosis/outcomes and interventions, respectively. The 54 new terms corresponded to 52 primitive concepts. An external review of The Catalogue showed that it had adequate understandability and validity. However, one-third of assessments/diagnoses/outcomes and one-fourth of interventions were not found in a tertiary hospital practice. CONCLUSION A fall-prevention catalogue has been developed based on evidence and a theoretical framework and also clinically validated. IMPLICATION FOR NURSING AND HEALTH POLICY The Catalogue is a standardized interface terminology and content subset in any electronic health records system that can directly deliver evidence on fall prevention. It can also be used as an informatics tool to aggregate, analyse, interpret and compare nursing data worldwide.
Collapse
Affiliation(s)
- I Cho
- Nursing Department, Inha University, Incheon, Korea
| | - J Kim
- Asan Medical Center, Seoul, Korea
| | - J S Chae
- Asan Medical Center, Seoul, Korea
| | - M Jung
- Department of Clinical Nursing, University of Ulsan, Ulsan, Korea
| | - Y H Kim
- Department of Clinical Nursing, University of Ulsan, Ulsan, Korea
| |
Collapse
|
50
|
Meaney KD, Kim YH, Herrmann HW, Geppert-Kleinrath H, Hoffman NM. Improved inertial confinement fusion gamma reaction history 12C gamma-ray signal by direct subtraction. Rev Sci Instrum 2019; 90:113503. [PMID: 31779396 DOI: 10.1063/1.5092501] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2019] [Accepted: 10/18/2019] [Indexed: 06/10/2023]
Abstract
The Gamma Reaction History (GRH) diagnostic located at the National Ignition Facility (NIF) measures time resolved gamma rays released from inertial confinement fusion experiments by converting the emitted gamma rays into Cherenkov light. Imploded capsules have a bright 4.4 MeV gamma ray from fusion neutrons inelastically scattering with carbon atoms in the remaining ablator. The strength of the 4.4 MeV gamma ray line is proportional to the capsule's carbon ablator areal density and can be used to understand the dynamics and energy budget of a carbon-based ablator capsule implosion. Historically, the GRH's four gas cells use the energy thresholding from the Cherenkov process to forward fit an estimation of the experiment's complete gamma ray spectrum by modeling the surrounding environment in order to estimate the 4.4 MeV neutron induced carbon gamma ray signal. However, the high number of variables, local minima, and uncertainties in detector sensitivities and relative timing had prevented the routine use of the forward fit to generate carbon areal density measurements. A new, more straightforward process of direct subtraction of deconvolved signals was developed to simplify the extraction of the carbon areal density. Beryllium capsules are used as a calibration to measure the capsule environment with no carbon signal. The proposed method is then used to appropriately subtract and isolate the carbon signal on shots with carbon ablators. The subtraction algorithm achieves good results across all major capsule campaigns, achieving similar results to the forward fit. This method is now routinely used to measure carbon areal density for NIF shots.
Collapse
Affiliation(s)
- K D Meaney
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - Y H Kim
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - H W Herrmann
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | | | - N M Hoffman
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| |
Collapse
|